Benign neoplasm: Caecum

CD2_BENIGN_CAECUM

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D12.0& Hospital discharge: ICD-8 — 21132 Cause of death: ICD-10 — D12.0& Cause of death: ICD-8 — 21132 2 out of 7 registries used, show all original rules.	3703
4. Check minimum number of events None	3703
5. Include endpoints None	3703
6. Filter based on genotype QC (FinnGen only)	3703

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: D12
Name in latin: Neoplasma benignum caeci

NAME	CD2_BENIGN_CAECUM
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D120
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	21132
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D120
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	21132
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Benign neoplasm: Caecum based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Benign neoplasm: Caecum

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	17590	9035	8500
Only index persons	16774	8728	8046
Unadjusted period prevalence (%)
Whole population	0.25	0.26	0.24
Only index persons	0.31	0.32	0.31
Median age at first event (years)
Whole population	69.48	69.23	69.74
Only index persons	69.27	69.08	69.49

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	3703	1881	1822
Unadjusted period prevalence (%)	0.72	0.64	0.80
Median age at first event (years)	68.55	67.35	69.78

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
3220: Matched controls
32198

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

19.1

323.0

1119

871

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

4503599627370496.0

323.0

3200

UJF32

NOMESCO Finland

Coloscopy

14.1

323.0

2463

6036

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

20.1

323.0

692

432

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

18.6

309.9

494

310

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

10.9

289.4

592

653

UJF30

NOMESCO Finland

Ileoscopy through colon

6.5

289.1

859

1712

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

4.2

255.6

1242

4168

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

9.6

238.2

519

630

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

7.8

236.5

595

914

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

16.1

214.0

359

249

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.4

214.0

1547

6955

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

13.9

155.8

277

217

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

12.9

114.5

209

172

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.3

98.8

1312

7407

A06AC01

ATC

ispaghula (psylla seeds); oral

2.4

93.1

1076

5633

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

3.2

79.8

466

1604

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.0

73.5

1697

11623

JFB21

NOMESCO Finland

Laparoscopic ileocaecal resection

76.9

66.3

A02BC02

ATC

pantoprazole; systemic

1.9

65.5

2239

17372

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.7

65.2

513

2127

N02BE01

ATC

paracetamol; systemic, rectal

2.5

64.9

2870

24763

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

60.5

831

4538

B01AB05

ATC

enoxaparin; parenteral

1.9

55.4

1178

7565

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.9

55.1

378

1431

D37.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Colon

6.2

53.1

148

247

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

3.2

52.2

296

984

JFA42

NOMESCO Finland

Endoscopic injection in colon

21.3

49.3

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.4

47.5

464

2134

K63.5

ICD-10 Finland

Polyp of colon

7.5

47.2

114

156

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.6

44.6

351

1435

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.0

44.5

631

3428

WX002

NOMESCO Finland

Sedation and analgesia

1.9

42.7

775

4616

JN3AD

NOMESCO Finland

Abdominal CT examination

2.6

41.3

338

1412

D12.1

ICD-10 Finland

Benign neoplasm: Appendix

24.1

40.1

JN4BD

NOMESCO Finland

Extensive body CT

2.1

39.8

481

2433

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.5

37.2

309

1296

JFA52

NOMESCO Finland

Other endoscopic haemostatic procedure in colon

15.5

37.0

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.1

36.9

495

2610

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

36.3

425

2113

A02BC05

ATC

esomeprazole; systemic

1.6

36.0

1332

9745

D12.7

ICD-10 Finland

Benign neoplasm: Rectosigmoid junction

7.1

36.0

130

R06.0

ICD-10 Finland

Dyspnoea

1.7

35.7

875

5697

N02AX02

ATC

tramadol; systemic, rectal

1.6

35.4

1411

10514

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

2.8

35.3

237

879

A02BC03

ATC

lansoprazole; oral

1.7

35.2

1018

6951

J01DB01

ATC

cefalexin; oral

1.7

35.0

2554

22232

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

33.8

917

6132

H02AB06

ATC

prednisolone; systemic

1.6

32.9

1499

11473

UJH02

NOMESCO Finland

Anoscopy

3.1

32.5

188

632

P01AB01

ATC

metronidazole; oral, rectal

1.6

31.2

1199

8760

JN4AD

NOMESCO Finland

Body CT examination

2.2

31.1

333

1584

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

9.0

30.8

K92.1

ICD-10 Finland

Melaena

2.6

30.7

232

923

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

30.6

726

4645

S18

ICPC

Laceration/cut

1.6

30.5

1422

10870

JFB30

NOMESCO Finland

Right hemicolectomy

4.9

30.1

101

212

C03CA01

ATC

furosemide; systemic

1.6

30.0

1053

7498

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

30.0

390

2017

SPAT1153

SPAT

Removal of sutures

1.6

29.7

1117

8087

D01

ICPC

Abdominal pain/cramps general

2.2

29.1

331

1618

AA1AD

NOMESCO Finland

CT of head and brain

1.6

28.7

856

5828

8263/2-C18.0

ICD-O-3

Adenocarcinoma in situ in tubulovillous adenoma of cecum

151.3

28.7

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

28.5

938

6553

C05AA08

ATC

fluocortolone; rectal, topical

1.9

28.4

499

2889

D12.9

ICD-10 Finland

Benign neoplasm: Anus and anal canal

7.9

28.2

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.6

27.9

1045

7526

C07AB07

ATC

bisoprolol; oral

1.5

27.9

1663

13336

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.2

27.7

312

1517

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

3.6

27.1

128

370

A02BC01

ATC

omeprazole; systemic

1.6

27.0

920

6464

UKC02

NOMESCO Finland

Cystoscopy

1.7

26.2

607

3830

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

5.9

26.1

128

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

6.5

26.0

106

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

25.5

574

3591

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

9.6

25.4

TPH07

NOMESCO Finland

Cathetrisation of artery

1.9

25.1

390

2155

SPAT1104

SPAT

Monitoring of emergency patient

2.2

25.0

263

1237

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

24.9

1127

8435

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.0

24.8

327

1695

J01MA12

ATC

levofloxacin; systemic

1.7

24.4

642

4196

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

24.4

1235

9458

J01CA04

ATC

amoxicillin; systemic

1.5

24.1

2361

20738

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

23.8

1191

9084

JFB20

NOMESCO Finland

Ileocaecal resection

10.6

23.8

M54.5

ICD-10 Finland

Low back pain

1.5

23.5

943

6842

J01AA02

ATC

doxycycline; systemic

1.5

23.5

2407

21271

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.7

23.5

587

3776

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

9.5

23.5

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

23.3

1090

8185

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

23.3

504

3107

N03AX16

ATC

pregabalin; oral

1.6

23.3

761

5257

G47.3

ICD-10 Finland

Sleep apnoea

1.6

23.0

658

4393

WX110

NOMESCO Finland

Local anesthesy

1.5

22.9

1969

16718

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

22.7

547

3477

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.2

22.7

120

379

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.3

22.5

208

919

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.0

22.4

325

1747

R03AC02

ATC

salbutamol; inhalant

1.4

22.3

1508

12177

B01AA03

ATC

warfarin; systemic

1.6

21.9

736

5103

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.5

21.9

848

6083

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.5

21.8

178

739

N06AX11

ATC

mirtazapine; oral

1.5

21.4

939

6924

A06AC51

ATC

ispaghula, combinations; systemic

2.4

21.4

181

766

A98

ICPC

Health maint/preventive medicine

1.9

21.4

2985

28059

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.9

21.4

321

1750

8140/3-C18.0

ICD-O-3

Adenocarcinoma, NOS, of cecum

6.8

21.3

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

3.4

21.1

103

307

A07EC02

ATC

mesalazine; oral, rectal

2.4

21.0

182

781

M79.6

ICD-10 Finland

Pain in limb

1.5

20.7

1074

8190

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

20.5

498

3164

D06

ICPC

Abdominal pain localized other

2.1

20.4

249

1251

R4110

NOMESCO Finland

Physiotherapy

1.5

20.3

830

6012

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.1

20.3

237

1168

SPAT1263

SPAT

Sampling

1.4

20.3

1301

10337

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

20.1

313

1728

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

5.0

19.7

131

J01FA06

ATC

roxithromycin; oral

1.4

19.7

1194

9366

A02BC04

ATC

rabeprazole; oral

2.0

19.5

265

1391

Z09.8

ICD-10 Finland

Follow-up examination after other treatment for other conditions

3.0

19.4

112

377

UJF92

NOMESCO Finland

Capsular endoscopy

3.5

19.4

264

H02AB04

ATC

methylprednisolone; systemic

1.7

19.3

456

2871

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

2.0

19.0

267

1416

R01AD09

ATC

mometasone; nasal

1.4

18.9

1181

9296

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

18.8

498

3235

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

18.6

576

3895

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

3.0

18.3

106

359

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.6

18.2

520

3443

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

17.9

169

756

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

17.8

936

7110

ZX120

NOMESCO Finland

Intravenous

1.8

17.8

313

1798

C180, 8211, 2

ICD-O-3

180.9

17.5

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.7

17.5

370

2256

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

3.7

17.1

206

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

17.1

1388

11390

G04CA02

ATC

tamsulosin; oral

1.5

17.1

796

5889

Z80.0

ICD-10 Finland

Family history of malignant neoplasm of digestive organs

7.7

17.1

ICD-10 Finland

3.0

16.7

341

R06AE07

ATC

cetirizine; oral

1.4

16.7

1157

9224

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.5

16.7

130

528

A06AD11

ATC

lactulose; oral

1.6

16.6

473

3126

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

16.6

537

3664

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

16.5

473

3131

I50.9

ICD-10 Finland

Heart failure, unspecified

1.6

16.4

460

3028

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.5

16.4

550

3787

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.5

16.3

787

5861

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.6

16.2

408

2610

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

16.1

450

2960

C10AA05

ATC

atorvastatin; oral

1.4

16.1

1296

10582

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

16.1

1324

10854

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

16.1

604

4263

XKD00

NOMESCO Finland

Uroflowmetry

1.5

16.0

582

4074

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.7

16.0

358

2216

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.7

15.9

333

2021

C18.02

ICD-10 Finland

Malignant tumor of caecum carcinoma of adenoma

14.5

15.8

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.4

15.8

140

609

R02

ICPC

Shortness of breath/dyspnoea

1.7

15.8

378

2387

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

3.4

15.7

233

D11

ICPC

Diarrhoea

1.8

15.5

263

1491

N05CF01

ATC

zopiclone; oral

1.4

15.4

993

7785

R03BA02

ATC

budesonide; inhalant

1.6

15.4

479

3233

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.4

15.4

781

5861

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

3.9

15.3

160

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.1

15.2

180

892

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

15.1

735

5466

207

Kela drug reimbursment

Chronic arrhythmias

1.5

15.0

531

3691

K59.0

ICD-10 Finland

Constipation

2.0

15.0

185

931

J01MA02

ATC

ciprofloxacin; systemic

1.4

15.0

1202

9771

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.0

14.8

190

974

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

14.8

210

1117

21132

ICD-8 Finland

Benign neoplasm of other parts of digestive system, Caeci

+∞

14.6

S82

ICPC

Naevus/mole

1.6

14.4

355

2254

S29

ICPC

Skin symptom/complaint other

1.5

14.4

505

3501

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

14.3

239

1347

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

3.3

14.3

228

K30

ICD-10 Finland

Functional dyspepsia

1.7

14.3

301

1827

M25.5

ICD-10 Finland

Pain in joint

1.4

14.3

745

5605

R03AC03

ATC

terbutaline; inhalant

1.6

14.2

387

2524

B01AB10

ATC

tinzaparin; parenteral

1.8

14.2

238

1344

JFB51

NOMESCO Finland

Other laparoscopic resection of colon

22.3

14.2

R05

ICD-10 Finland

Cough

1.5

14.2

559

3974

SPAT1216

SPAT

Assessment of functional ability

1.5

14.2

525

3681

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.1

14.1

154

738

UJG02

NOMESCO Finland

Proctoscopy

2.9

14.1

301

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

14.1

415

2761

SAA01

NOMESCO Finland

Simple examination of mouth

1.3

14.1

1876

16450

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.7

14.0

364

SAA02

NOMESCO Finland

Basic examination of mouth

1.3

13.9

1655

14252

N03AX12

ATC

gabapentin; oral

1.5

13.9

462

3161

K64.0

ICD-10 Finland

First degree haemorrhoids

3.7

13.8

165

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.9

13.8

210

1148

TJX00

NOMESCO Finland

Punkture or biopsy in gastrointestinal endoscopy

20.1

13.8

R42

ICD-10 Finland

Dizziness and giddiness

1.4

13.7

665

4932

ZXA00

NOMESCO Finland

Right side

1.4

13.7

849

6588

K55.2

ICD-10 Finland

Angiodysplasia of colon

5.4

13.6

R03BB04

ATC

tiotropium bromide; inhalant

1.6

13.6

331

2095

B80

ICPC

Iron deficiency anaemia

3.1

13.6

243

M48.0

ICD-10 Finland

Spinal stenosis

1.6

13.5

402

2678

A04

ICPC

Weakness/tiredness general

1.6

13.5

378

2478

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

13.5

241

1390

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.9

13.5

204

1113

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.0

13.5

176

910

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

13.4

668

4976

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.8

13.3

255

1505

R53

ICD-10 Finland

Malaise and fatigue

1.5

13.3

572

4139

M01AH05

ATC

etoricoxib; oral

1.3

13.2

1627

14034

8140/3-C19.9

ICD-O-3

Adenocarcinoma, NOS, of rectosigmoid junction

9.1

13.2

D19

ICPC

Teeth/gum symptom/complaint

1.4

13.2

633

4677

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

13.1

162

820

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

13.0

352

2291

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

13.0

396

2653

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

13.0

330

2111

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.2

13.0

132

615

J45.1

ICD-10 Finland

Nonallergic asthma

1.9

13.0

209

1163

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.4

13.0

720

5467

B01AF02

ATC

apixaban; oral

1.6

12.9

345

2237

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.4

12.9

693

5231

L04AX01

ATC

azathioprine; systemic

2.3

12.9

123

555

L17

ICPC

Foot/toe symptom/complaint

1.4

12.9

745

5697

I10

ICD-10 Finland

Essential (primary) hypertension

1.3

12.9

1953

17330

WX722

NOMESCO Finland

PEEP

2.0

12.8

158

798

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

2.3

12.8

122

550

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.9

12.8

281

B82

ICPC

Anaemia other/unspecified

2.6

12.8

360

L01BC06

ATC

capecitabine; oral

2.2

12.8

132

619

L03

ICPC

Low back symptom/complaint

1.4

12.7

664

4980

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.8

12.7

227

1310

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

2.1

12.7

144

703

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

12.7

362

2387

D02

ICPC

Abdominal pain epigastric

2.0

12.7

168

874

J45

ICD-10 Finland

Asthma

1.7

12.7

266

1614

JFA85

NOMESCO Finland

Endoscopic mucosal or submucosal resection in colon

12.3

12.6

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.4

12.6

104

439

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.4

12.6

573

4191

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.4

12.5

732

5606

WX402

NOMESCO Finland

General anaesthesia

1.5

12.5

446

3097

B01AF01

ATC

rivaroxaban; oral

1.5

12.5

408

2778

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

12.4

921

7338

D13.2

ICD-10 Finland

Benign neoplasm: Duodenum

5.3

12.4

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.8

12.3

232

1360

WZA90

NOMESCO Finland

Other doctors statement

1.4

12.3

601

4452

H02AB07

ATC

prednisone; oral

1.5

12.3

417

2864

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.4

12.3

105

451

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

12.3

1463

12513

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.3

12.3

118

534

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

12.2

108

471

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

12.2

1381

11716

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

2.3

12.2

113

503

103

Kela drug reimbursment

Diabetes, insulin-treated

1.4

12.2

836

6576

E0000UV

ATC

1.3

12.2

1076

8808

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.1

12.1

135

655

R35

ICD-10 Finland

Polyuria

1.8

12.1

207

1176

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

6.1

12.1

J02AC01

ATC

fluconazole; systemic

1.3

12.0

983

7950

N06AX21

ATC

duloxetine; oral

1.7

11.9

277

1731

A03FA02

ATC

cisapride; oral, rectal

1.7

11.9

237

1415

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.0

11.9

159

829

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.9

11.9

183

1006

S21

ICPC

Skin texture symptom/complaint

1.5

11.9

372

2508

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

11.8

748

5802

NF1AA

NOMESCO Finland

Hip X-ray examination

1.6

11.8

280

1760

XF404

NOMESCO Finland

Ambulatory ECG

1.6

11.8

311

2009

L13

ICPC

Hip symptom/complaint

1.5

11.7

480

3435

C19

ICD-10 Finland

Malignant neoplasm of rectosigmoid junction

5.2

11.6

A01

ICPC

Pain general/multiple sites

1.7

11.6

229

1363

SPAT1312

SPAT

General health counselling

1.3

11.5

890

7127

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

11.4

149

771

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

11.3

864

6898

D07AC01

ATC

betamethasone; topical

1.3

11.3

956

7754

J01MA14

ATC

moxifloxacin; systemic

1.6

11.2

265

1663

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

11.2

1018

8342

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

11.1

300

1947

SPAT1254

SPAT

Administration of medicine

1.5

11.1

446

3172

JAH01

NOMESCO Finland

Laparoscopy

2.1

11.1

118

560

WX892

NOMESCO Finland

Monitored bed care

1.7

11.1

233

1413

A11

ICPC

Chest pain NOS

1.7

11.1

241

1475

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.6

11.1

329

2188

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

11.1

442

3140

JGB00

NOMESCO Finland

Partial proctectomy and colorectal or coloanal anastomosis

5.2

11.0

SPAT1097

SPAT

Recording of ECG

1.4

11.0

490

3558

-60

ICPC

Result test/procedure

1.8

11.0

192

1103

I84.1

ICD-10 Finland

Internal hemorrhoids with other complications

2.5

11.0

330

G04BD12

ATC

mirabegron; oral

1.6

10.9

331

2213

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

2.5

10.9

325

R03BA05

ATC

fluticasone; inhalant

1.5

10.9

460

3308

K51.5

ICD-10 Finland

Left sided colitis

2.6

10.8

293

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

10.8

227

1376

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.3

10.8

1057

8742

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.7

10.8

218

1307

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.6

10.8

302

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.4

10.7

616

4689

A10AE04

ATC

insulin glargine; parenteral

1.6

10.7

279

1797

WX290

NOMESCO Finland

Other blockade of nerve

1.3

10.7

982

8044

D12

ICPC

Constipation

2.1

10.7

115

550

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.5

10.7

384

2670

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

10.7

718

5612

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.7

10.6

256

JFB47

NOMESCO Finland

Laparoscopic resection of sigmoid colon

3.4

10.6

149

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.7

10.6

220

1331

K02.1

ICD-10 Finland

Caries of dentine

1.3

10.6

1413

12177

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

10.6

299

1966

R03DC03

ATC

montelukast; oral

1.5

10.6

395

2765

B01AB04

ATC

dalteparin; parenteral

1.9

10.6

159

870

I84

ICD-10 Finland

Hemorrhoids

2.3

10.5

425

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.0

10.5

138

717

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

10.5

1235

10467

SPAT1255

SPAT

Intravenous administration of medicine

1.7

10.5

203

1202

-50

ICPC

Medication/prescr/renewal

2.0

10.5

140

733

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.2

10.5

109

516

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.4

10.4

489

3583

J01FF01

ATC

clindamycin; systemic

1.3

10.4

747

5890

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

10.4

936

7641

N05BA04

ATC

oxazepam; oral

1.4

10.4

674

5229

A07EA06

ATC

budesonide; oral, local oral

2.3

10.4

421

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

10.4

199

1174

TK800

NOMESCO Finland

Hemodialysis

2.5

10.4

307

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

10.4

462

3354

SPAT1301

SPAT

No procedures

1.3

10.4

966

7923

SPAT1325

SPAT

Vaccination

1.3

10.4

1095

9140

D16

ICPC

Rectal bleeding

2.6

10.3

283

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

10.3

270

1738

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.4

10.3

478

3495

JEA01

NOMESCO Finland

Laparoscopic appendectomy

2.4

10.3

347

M70.6

ICD-10 Finland

Trochanteric bursitis

1.5

10.3

341

2329

K60.1

ICD-10 Finland

Chronic anal fissure

2.8

10.3

237

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.8

10.3

189

1101

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

10.2

454

3296

379

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the long-term prevention of recurrent deep veinthrombosis and pulmonary embolism

2.6

10.2

287

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.4

10.2

645

4985

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.6

10.2

253

1612

JN4CD

NOMESCO Finland

Very extensive body CT

1.9

10.2

138

728

F45.8

ICD-10 Finland

Other somatoform disorders

2.0

10.2

127

648

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.6

10.1

298

R50.9

ICD-10 Finland

Fever, unspecified

1.5

10.1

374

2615

C18.79

ICD-10 Finland

Malignant tumor of the sigmoid or other unspecified histology

5.6

10.1

R03BC03

ATC

nedocromil; inhalant

1.7

10.1

198

1179

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

3.4

10.0

135

R01AD05

ATC

budesonide; nasal

1.7

10.0

197

1177

D50.8

ICD-10 Finland

Other iron deficiency anaemias

3.1

9.9

174

M01AE02

ATC

naproxen; oral, rectal

1.3

9.9

1506

13156

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

9.9

1068

8925

SFA00

NOMESCO Finland

Small filling

1.5

9.9

316

2140

T90

ICPC

Diabetes non-insulin dependent

1.3

9.8

722

5708

G44.2

ICD-10 Finland

Tension-type headache

1.5

9.8

321

2183

D12

ICD-10 Finland

Benign neoplasm of colon, rectum, anus and anal canal

5.9

9.8

C03DA01

ATC

spironolactone; oral

1.5

9.7

333

2289

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

9.7

1089

9146

Z01.2

ICD-10 Finland

Dental examination

1.3

9.7

1007

8372

A07EA02

ATC

hydrocortisone; rectal

2.5

9.7

296

K04

ICPC

Palpitations/awareness of heart

1.9

9.6

143

778

R19.4

ICD-10 Finland

Change in bowel habit

2.4

9.6

316

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

2.4

9.6

335

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

9.6

217

1348

N05CF02

ATC

zolpidem; oral

1.4

9.6

451

3307

J01FA09

ATC

clarithromycin; systemic

1.3

9.5

800

6447

M54.2

ICD-10 Finland

Cervicalgia

1.7

9.5

191

1143

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

6.0

9.5

J46

ICD-10 Finland

Status asthmaticus

2.3

9.5

370

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

9.5

170

987

UJD02

NOMESCO Finland

Gastroscopy

1.8

9.5

148

822

J01DA01

ATC

[U] cefalexin; systemic

1.3

9.4

1759

15713

K78

ICPC

Atrial fibrillation/flutter

1.6

9.4

268

1765

SPAT1310

SPAT

Counselling related to known health issue

1.3

9.4

914

7520

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

9.4

1427

12434

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.6

9.4

272

1798

C180, 8148, 2

ICD-O-3

+∞

9.4

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

9.4

676

5327

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.4

9.4

593

4576

-45

ICPC

Observ/health educat/advice/diet

2.2

9.3

440

XF402

NOMESCO Finland

ECG with work load test

1.5

9.3

356

2507

WZC30

NOMESCO Finland

Teaching

1.4

9.3

387

2773

L86

ICPC

Back syndrome with radiating pain

1.8

9.2

162

936

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

9.1

876

7194

D37.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Rectum

3.6

9.1

109

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.0

9.0

116

599

A27

ICPC

Fear of other disease NOS

1.9

9.0

122

641

JGA05

NOMESCO Finland

Endoscopic polypectomy in rectum

4.2

9.0

I80.29

ICD-10 Finland

Phlebitis and thrombophlebitis of other deep vessels of lower extremities

2.1

9.0

475

SPAT1260

SPAT

Consultation of another employee

1.4

8.9

515

3914

XQ800

NOMESCO Finland

Prick test

1.8

8.9

150

851

M54.6

ICD-10 Finland

Pain in thoracic spine

1.8

8.9

152

869

M04AA01

ATC

allopurinol; systemic

1.4

8.9

410

2995

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

8.9

584

4532

JF2BD

NOMESCO Finland

Extensive colon CT

3.3

8.8

133

D37.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Small intestine

4.8

8.8

R60.0

ICD-10 Finland

Localized oedema

1.5

8.8

326

2275

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

8.8

736

5920

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

1.5

8.8

270

1809

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.7

8.8

199

1235

R13

ICD-10 Finland

Dysphagia

1.7

8.8

191

1175

C10AC01

ATC

colestyramine; oral

2.3

8.8

359

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.4

8.8

485

3659

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.0

8.8

114

592

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.4

8.7

472

3545

A10BA02

ATC

metformin; oral

1.3

8.7

852

7000

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

2.9

8.7

178

L16

ICPC

Ankle symptom/complaint

1.5

8.7

257

1706

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.5

8.7

264

1766

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

8.7

454

3391

J01FA10

ATC

azithromycin; systemic

1.3

8.7

1429

12533

M03BX02

ATC

tizanidine; oral

1.2

8.6

1638

14598

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

8.6

262

1750

M01AX17

ATC

nimesulide; oral

1.3

8.6

734

5917

J20

ICD-10 Finland

Acute bronchitis

1.6

8.6

250

1656

-34

ICPC

Blood test

2.1

8.6

450

M79.1

ICD-10 Finland

Myalgia

1.5

8.5

317

2216

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.7

8.5

177

1075

D04

ICPC

Rectal/anal pain

3.1

8.5

148

K29.6

ICD-10 Finland

Other gastritis

3.1

8.5

148

C18.22

ICD-10 Finland

Malignant tumor of the colon ascending carcinoma of the adenoma

9.0

8.5

N01

ICPC

Headache

1.7

8.5

190

1178

JFG10

NOMESCO Finland

Closure of loop colostomy without resection

3.7

8.5

R11

ICD-10 Finland

Nausea and vomiting

1.6

8.5

201

1264

E66.8

ICD-10 Finland

Other obesity

2.0

8.5

108

557

G04CA01

ATC

alfuzosin; oral

1.4

8.5

366

2637

K07.60

ICD-10 Finland

Snapping jaw

2.0

8.5

481

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

8.5

464

3494

Z51.4

ICD-10 Finland

Preparatory care for subsequent treatment, not elsewhere classified

4.0

8.4

XW000

NOMESCO Finland

Bone marrow biopsy

1.9

8.4

126

691

C01AA05

ATC

digoxin; systemic

1.6

8.4

242

1599

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

8.4

472

3569

-35

ICPC

Urine test

3.0

8.4

150

J05AB11

ATC

valaciclovir; oral

1.4

8.3

341

2434

K80

ICPC

Cardiac arrhythmia NOS

1.6

8.3

221

1429

M01AE01

ATC

ibuprofen; systemic, rectal

1.3

8.3

2574

24263

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.8

8.3

136

768

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.4

8.3

459

3461

R07.3

ICD-10 Finland

Other chest pain

1.5

8.3

267

1810

M01AH01

ATC

celecoxib; oral (coxibs)

1.4

8.2

509

3907

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

8.2

459

PD1BD

NOMESCO Finland

Extensive CT of abdominal aorta and branches

3.3

8.2

119

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.5

8.2

303

2115

G04BD08

ATC

solifenacin; oral

1.6

8.2

213

1373

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

7.5

8.1

XJH00

NOMESCO Finland

Transanal ultrasonography

1.6

8.1

211

1361

U05

ICPC

Urination problems other

1.8

8.1

143

825

A02BA02

ATC

ranitidine; systemic

1.3

8.1

583

4584

U02

ICPC

Urinary frequency/urgency

1.4

8.1

355

2567

L05

ICPC

Flank/axilla symptom/complaint

1.7

8.1

150

881

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

1.6

8.1

209

1347

R39.1

ICD-10 Finland

Other difficulties with micturition

2.0

8.0

461

R5140

NOMESCO Finland

Monitoring the use of the aid

1.5

8.0

281

1941

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.2

8.0

1251

10872

M01AC06

ATC

meloxicam; systemic, rectal

1.3

8.0

1014

8600

A41.8

ICD-10 Finland

Other specified sepsis

2.6

8.0

213

C18.60

ICD-10 Finland

Malignant tumor of the descending colon without histology

7.2

7.9

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.6

7.9

181

1130

M02AA07

ATC

piroxicam; topical

1.3

7.9

1056

9006

C20.92

ICD-10 Finland

Malignant tumor of the rectum carcinoma of the adenoma

3.9

7.9

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.6

7.9

200

1282

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

7.9

164

995

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.7

7.9

162

978

R15

ICD-10 Finland

Faecal incontinence

2.1

7.9

397

Z96.1

ICD-10 Finland

Presence of intraocular lens

1.4

7.8

397

2948

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.6

7.8

183

1149

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

7.8

1196

10362

K29.7

ICD-10 Finland

Gastritis, unspecified

1.9

7.8

105

555

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.6

7.8

184

1156

C01DA14

ATC

isosorbide mononitrate; oral

1.4

7.8

483

3706

A07AA02

ATC

nystatin; oral

1.6

7.8

179

1119

J01DA06

ATC

[U] cefuroxime; systemic

1.4

7.8

376

2768

R03BA08

ATC

ciclesonide; inhalant

1.6

7.7

201

1295

JF1BD

NOMESCO Finland

Very extensive small bowel CT

4.0

7.7

L29

ICPC

Musculoskeletal sympt/complt other

1.6

7.7

204

1319

JFB43

NOMESCO Finland

Left hemicolectomy

3.6

7.7

EMAK

NOMESCO Finland

2.0

7.7

493

R03AK11

ATC

formoterol and fluticasone; inhalant

2.3

7.7

286

L15

ICPC

Knee symptom/complaint

1.3

7.7

573

4524

R03BA01

ATC

beclometasone; inhalant

1.4

7.7

370

2719

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.5

7.7

294

2066

C18.61

ICD-10 Finland

Malignant tumor of the colon descending invasive carcinoma

6.4

7.7

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

7.7

1135

9784

C07AA05

ATC

propranolol; systemic

1.4

7.7

455

3465

R51.80

ICD-10 Finland

Headache

1.4

7.7

331

2386

C08CA01

ATC

amlodipine; oral

1.2

7.6

1125

9696

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.7

7.6

163

999

C07AB02

ATC

metoprolol; systemic

1.3

7.6

628

5032

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

4.7

7.6

R31

ICD-10 Finland

Unspecified haematuria

1.4

7.6

307

2185

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.4

7.6

464

3551

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

2.4

7.6

271

C18.72

ICD-10 Finland

Malignant tumor of sigmoid carcinoma of adenoma

4.9

7.6

C09CA06

ATC

candesartan; oral

1.3

7.5

587

4664

M01AB05

ATC

diclofenac; systemic, rectal

1.2

7.5

1851

16858

N06AA09

ATC

amitriptyline; systemic

1.5

7.5

286

2009

C01BC04

ATC

flecainide; systemic

1.9

7.5

112

613

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.2

7.5

326

D64.8

ICD-10 Finland

Other specified anaemias

2.5

7.5

210

A10BH05

ATC

linagliptin; oral

1.7

7.5

150

904

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.8

7.5

123

696

D18

ICPC

Change in faeces/bowel movements

2.3

7.4

298

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

7.4

544

4282

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.8

7.4

115

637

JFA97

NOMESCO Finland

Other laparoscopic local operation on intestine

80.2

7.4

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.3

7.4

885

7435

A05

ICPC

Feeling ill

1.8

7.4

115

638

N06AB04

ATC

citalopram; systemic

1.3

7.4

540

4251

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.3

7.4

521

4079

JGA73

NOMESCO Finland

Transanal excision of lesion of rectum

6.0

7.4

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.3

7.4

634

5107

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

7.3

690

5624

R96

ICPC

Asthma

1.5

7.3

231

1560

E000001

ATC

1.3

7.3

497

3871

SPAT1167

SPAT

Insertion of urinary catheter

1.8

7.3

109

599

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

1.7

7.3

143

854

-31

ICPC

Medical examin/health eval partial

1.6

7.3

201

1316

GD1AD

NOMESCO Finland

Thorax CT examination

1.7

7.3

131

764

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

1.6

7.3

160

989

A10BH01

ATC

sitagliptin; oral

1.4

7.3

289

2050

SPAT1262

SPAT

Handing over of treatment supplies

1.3

7.3

549

4342

D78

ICPC

Neoplasm digestive benign/unspecif

9.4

7.3

N06AB10

ATC

escitalopram; oral

1.4

7.3

417

3159

S97

ICPC

Chronic ulcer skin

1.6

7.3

166

1036

D93

ICPC

Irritable bowel syndrome

3.5

7.3

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

1.6

7.2

199

1303

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

2.1

7.2

399

NG1CG

NOMESCO Finland

Knee and lower leg extensive MRI examination with high intensity magnet

2.9

7.2

147

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

7.2

1813

16512

H53.1

ICD-10 Finland

Subjective visual disturbances

1.6

7.2

162

1008

M10.9

ICD-10 Finland

Gout, unspecified

1.6

7.2

198

1295

Z49.1

ICD-10 Finland

Extracorporeal dialysis

2.8

7.2

155

N17.9

ICD-10 Finland

Acute renal failure, unspecified

1.8

7.2

113

632

JFA84

NOMESCO Finland

Laparoscopic excision of lesion of colon

30.1

7.1

H93.1

ICD-10 Finland

Tinnitus

1.6

7.1

174

1105

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

2.3

7.1

292

F29

ICPC

Eye symptom/complaint other

1.5

7.1

211

1408

-62

ICPC

Administrative procedure

2.0

7.1

446

R03AC12

ATC

salmeterol; inhalant

1.7

7.1

127

740

L04

ICPC

Chest symptom/complaint

1.7

7.1

151

926

I35.0

ICD-10 Finland

Aortic (valve) stenosis

1.6

7.1

197

1295

SPAT1281

SPAT

Other administrative function

1.5

7.1

213

1423

I50

ICD-10 Finland

Heart failure

1.9

7.0

505

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.6

7.0

157

973

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.6

7.0

198

1304

XG410

NOMESCO Finland

Flow-volume spirometry

1.8

7.0

119

679

R52.9

ICD-10 Finland

Pain, unspecified

1.5

7.0

213

1429

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.4

7.0

374

2802

SDA02

NOMESCO Finland

Parodonthologic therapy

1.3

7.0

795

6638

S10

ICPC

Boil/carbuncle

1.7

7.0

131

773

J37.0

ICD-10 Finland

Chronic laryngitis

1.9

6.9

471

R03AK08

ATC

formoterol and beclometasone; inhalant

1.9

6.9

514

C10AA01

ATC

simvastatin; oral

1.2

6.9

1439

12828

R06AX27

ATC

desloratadine; oral

1.3

6.9

561

4477

L01

ICPC

Neck symptom/complaint

1.4

6.9

338

2490

C09DA01

ATC

losartan and diuretics; oral

1.4

6.9

310

2249

C09CA01

ATC

losartan; oral

1.3

6.9

719

5934

J01MA06

ATC

norfloxacin; oral

1.4

6.9

356

2652

E66.01

ICD-10 Finland

Obesity due to excess calories

1.6

6.9

157

979

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.7

6.9

125

731

I48.2

ICD-10 Finland

Chronic atrial fibrillation

2.0

6.9

451

M35.3

ICD-10 Finland

Polymyalgia rheumatica

1.7

6.9

125

733

XCD10

NOMESCO Finland

Electrophysiological examination of eye

2.1

6.9

339

C20.99

ICD-10 Finland

Malignant tumor of the rectum other or unspecified histology

3.7

6.8

A46

ICD-10 Finland

Erysipelas

1.4

6.8

398

3024

L08

ICPC

Shoulder symptom/complaint

1.3

6.8

516

4078

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.8

6.8

110

618

K62.3

ICD-10 Finland

Rectal prolapse

2.6

6.8

172

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.9

6.8

482

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

1.5

6.8

206

1381

A11CC03

ATC

alfacalcidol; systemic

2.1

6.8

333

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.8

6.7

102

563

C18.09

ICD-10 Finland

Malignant tumor of caecum other or unspecified histology

5.6

6.7

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

1.6

6.7

187

1230

R01AD08

ATC

fluticasone; nasal

1.3

6.7

675

5547

205

Kela drug reimbursment

Chronic hypertension

1.2

6.7

877

7434

I47.1

ICD-10 Finland

Supraventricular tachycardia

1.8

6.7

111

633

K55.8

ICD-10 Finland

Other vascular disorders of intestine

4.1

6.7

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

6.7

177

1147

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

1.8

6.7

116

670

JF1AD

NOMESCO Finland

Small bowel CT

3.9

6.7

JEA00

NOMESCO Finland

Appendectomy

1.7

6.6

140

855

K86.2

ICD-10 Finland

Cyst of pancreas

3.1

6.6

106

A07AA09

ATC

vancomycin; oral

2.7

6.6

162

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prothetic work

1.7

6.6

135

819

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

5.2

6.6

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.5

6.6

224

1536

I84.5

ICD-10 Finland

External hemorrhoids without complication

1.9

6.6

458

R01AD01

ATC

beclometasone; nasal

1.4

6.6

362

2724

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

6.6

320

2357

A04.8

ICD-10 Finland

Other specified bacterial intestinal infections

2.5

6.6

188

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

2.4

6.6

214

JGB06

NOMESCO Finland

Partial proctectomy with total excision of mesorectum

4.0

6.6

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

2.0

6.6

407

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

6.5

659

5410

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.3

6.5

646

5294

3AC01

NOMESCO Finland

3.1

6.5

108

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

3.1

6.5

108

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

3.2

6.5

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

1.9

6.5

484

UJF02

NOMESCO Finland

Peroral enteroscopy

3.7

6.5

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.7

6.5

123

731

JDA05

NOMESCO Finland

Endoscopic polypectomy in stomach or pylorus

3.8

6.5

JG1BG

NOMESCO Finland

MRI of rectum

3.3

6.4

Z95.2

ICD-10 Finland

Presence of prosthetic heart valve

2.0

6.4

390

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

6.4

622

5080

A02BA03

ATC

famotidine; systemic

1.7

6.4

114

663

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

6.4

203

1374

NA7DG

NOMESCO Finland

Spine and spinal cord very extensive MRI examination with high intensity magnet

3.0

6.4

109

SPAT1240

SPAT

Therapeutic discussion

1.5

6.4

194

1301

K92.0

ICD-10 Finland

Haematemesis

2.1

6.4

330

SPAT1210

SPAT

Application of cast or individual aid

1.8

6.4

108

617

K80.0

ICD-10 Finland

Calculus of gallbladder with acute cholecystitis

1.7

6.4

119

704

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

6.4

166

1072

K50.8

ICD-10 Finland

Other Crohn disease

2.9

6.4

121

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.6

6.4

155

985

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

1.8

6.3

510

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.3

6.3

647

5322

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.4

6.3

327

2437

C10AA07

ATC

rosuvastatin; oral

1.3

6.3

716

5965

K07

ICPC

Swollen ankles/oedema

1.7

6.3

130

789

L57.0

ICD-10 Finland

Actinic keratosis

1.4

6.3

308

2272

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.5

6.3

233

1633

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.7

6.3

130

794

L14

ICPC

Leg/thigh symptom/complaint

1.5

6.3

207

1416

K573, D120

ICD-10 Finland

+∞

6.2

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

6.2

302

2223

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.6

6.2

141

879

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

1.6

6.2

141

879

R01BA52

ATC

pseudoephedrine, combinations; oral

1.2

6.2

779

6558

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.5

6.2

228

1592

R05FB02

ATC

cough suppressants and expectorants

1.2

6.2

1057

9202

K60.2

ICD-10 Finland

Anal fissure, unspecified

2.6

6.2

157

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3022145) Colonoscopy Study observation

1615

3543

7.31

307.65

1.6

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

982

3921

3.05

176.43

4.4

4.1

ug/l

5.3

22.9

4.55

832

3228

(3048689) Calprotectin [Mass/mass] in Stool

793

3209

2.87

135.29

2.1

ug/g

145.3

154.9

0.28

636

2476

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1553

8661

2.37

135.16

2.9

2.3

mg/l

3.3

3.0

3.47

1386

7338

(3024561) Albumin [Mass/volume] in Serum or Plasma

2252

14981

2.28

125.43

6.0

4.9

g/l

35.0

34.9

0.22

2156

13858

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

2505

17500

2.33

122.89

7.4

6.4

umol/l

11.3

11.8

1.28

2402

16604

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1951

12547

2.17

114.03

3.7

2.8

ug/l

133.8

151.5

1.78

1813

11400

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

3190

25291

2.89

111.98

10.3

7.9

u/l

79.7

79.8

0.05

3068

23728

(40768797) Stomach Pathology biopsy report

949

4561

2.45

111.93

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

1671

10561

2.06

97.18

3.0

2.5

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1654

10453

2.05

95.81

3.0

2.6

u/l

59.3

58.7

0.10

1546

9592

(40768804) Tissue Pathology biopsy report

1932

13067

2.00

90.85

2.6

2.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1007

5420

2.18

87.94

3.1

2.6

umol/l

11.8

12.5

2.09

945

5006

(3013650) Neutrophils [#/volume] in Blood by Automated count

2485

18485

2.05

87.72

10.2

9.2

e9/l

4.2

0.06

2201

16033

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2152

15226

1.99

87.58

4.8

4.2

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1348

8117

2.04

87.18

2.9

2.4

—

(3013115) Eosinophils [#/volume] in Blood

2270

16383

2.00

86.95

7.1

5.9

e9/l

0.2

0.01

2009

14172

(3006315) Basophils [#/volume] in Blood

2211

15864

1.98

85.50

6.9

5.7

e9/l

0.0

1.25

1949

13519

(3007164) IgA [Mass/volume] in Serum or Plasma

982

5311

2.16

84.16

1.6

1.5

g/l

2.6

0.10

575

3076

(3001604) Monocytes [#/volume] in Blood

2196

15783

1.96

83.74

6.9

5.7

e9/l

0.6

1.91

1936

13438

(3019198) Lymphocytes [#/volume] in Blood

2233

16140

1.97

83.74

6.9

5.8

e9/l

1.9

0.07

1969

14003

(3004789) Transferrin [Mass/volume] in Serum or Plasma

943

5040

2.17

83.17

3.1

2.6

g/l

2.4

2.3

3.91

882

4652

(3013707) Erythrocyte sedimentation rate by Westergren method

2957

23712

2.23

82.16

5.6

4.2

mm/h

14.8

13.7

3.26

2769

21715

(3031040) Bacteria [#/volume] in Urine by Automated count

2756

21553

2.09

81.18

6.1

4.9

e6/l

132.1

1819.2

3.57

345

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1060

5975

2.08

81.00

1.3

1.2

u/ml

1.5

1.8

0.40

241

1494

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

888

4730

2.15

78.39

3.1

2.6

20.6

22.3

2.85

791

3990

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2031

14533

1.88

74.96

2.4

2.1

pmol/l

94.7

94.2

0.18

1169

7422

(3013826) Glucose [Moles/volume] in Serum or Plasma

2554

19808

1.93

71.96

6.4

4.8

mmol/l

6.9

6.8

0.87

2442

18646

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2150

15929

1.83

68.24

7.9

6.1

mmol/l

1.2

2.84

1992

14339

(3032080) INR in Blood by Coagulation assay

2006

14590

1.82

67.28

12.3

10.5

inr

1.3

0.09

434

4047

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

448

1891

2.56

67.08

2.8

2.5

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

3484

30812

3.21

66.17

24.5

16.4

mg/l

26.0

25.7

0.21

3026

24927

(3037467) Urinalysis macro (dipstick) panel - Urine

2740

22181

1.90

62.33

5.8

4.6

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

2283

17534

1.79

61.05

9.3

6.9

mmol/l

1.2

3.22

2028

14730

(3014576) Chloride [Moles/volume] in Serum or Plasma

809

4557

1.99

59.31

8.1

6.6

mmol/l

104.5

104.3

0.34

797

4448

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1831

13299

1.75

58.52

5.0

3.9

ng/l

57.8

85.4

0.37

1408

9987

(3033658) Prothrombin time (PT) actual/Normal

1276

8388

1.80

57.47

5.3

4.0

86.6

87.1

0.25

1248

8194

(40758558) Short blood count panel - Blood

1236

8098

1.79

55.98

7.1

6.8

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1579

11121

1.73

55.33

3.6

3.1

ng/l

1836.1

1526.3

1.11

1392

9670

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

525

2576

2.21

55.27

1.8

1.6

—

(3027945) Reticulocytes/100 erythrocytes in Blood

757

4267

1.97

54.91

2.5

1.8

0.09

678

3754

(3011397) Hemoglobin [Presence] in Urine by Test strip

1164

7551

1.79

54.15

5.2

3.9

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

2385

18880

1.74

53.95

4.3

3.2

u/l

63.4

54.3

3.29

2222

17193

(40761535) Cells panel - Urine sediment

569

2916

2.12

53.52

4.7

3.6

—

(42870588) Differential panel, method unspecified - Blood

1578

11203

1.71

53.03

6.7

5.8

—

(40761511) CBC panel - Blood by Automated count

3494

31563

2.90

51.81

23.3

15.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

948

5889

1.82

50.34

3.1

2.9

e6/l

1.0

1.2

0.58

626

3391

(3000570) Elastase.pancreatic [Mass/mass] in Stool

265

996

2.79

49.57

1.5

ug/g

258.1

266.5

0.28

161

595

(3035350) Ketones [Presence] in Urine by Test strip

2021

15511

1.67

49.17

5.1

3.9

estimate

0.0

0.00

237

2917

(3019309) Folate [Moles/volume] in Red Blood Cells

1077

7020

1.75

48.20

1.9

1.8

nmol/l

1133.6

1170.3

0.59

840

5196

(3019069) Monocytes/100 leukocytes in Blood

1951

14931

1.65

47.21

7.5

6.3

8.9

0.04

1831

13869

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

3216

28274

2.05

47.02

5.8

4.9

mu/l

2.0

2.1

1.07

2984

25390

(3018010) Neutrophils/100 leukocytes in Blood

1952

14976

1.64

46.47

6.9

5.9

58.5

58.0

0.99

1815

13898

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

598

3279

1.98

46.23

2.5

2.2

g/l

0.2

1.95

560

3044

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

723

4225

1.88

46.20

3.9

4.2

u/l

229.9

245.9

2.92

685

3974

(3009261) Glucose [Presence] in Urine by Test strip

2030

15752

1.64

45.98

5.3

4.0

estimate

0.0

1.08

246

2862

(3019550) Sodium [Moles/volume] in Serum or Plasma

3545

32531

3.10

45.95

28.7

19.3

mmol/l

139.7

139.6

0.09

3500

31712

(3003327) Ova and parasites identified in Stool by Light microscopy

230

835

2.87

45.85

1.9

1.7

—

(3023520) Reticulocytes [#/volume] in Blood

592

3249

1.98

45.60

2.6

2.5

e9/l

67.1

69.1

0.75

467

2455

(3002030) Lymphocytes/100 leukocytes in Blood

1970

15193

1.63

45.56

7.2

6.2

26.2

26.7

1.03

1828

14027

(3006504) Eosinophils/100 leukocytes in Blood

1935

14862

1.63

45.46

7.1

6.0

2.8

0.18

1821

13757

(3014111) Lactate [Moles/volume] in Serum or Plasma

575

3131

1.99

45.28

7.7

6.7

mmol/l

1.3

1.4

0.50

554

3023

(3023368) Bacteria identified in Blood by Culture

1394

9900

1.65

44.55

5.0

4.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

3543

32598

3.01

43.83

28.8

19.5

mmol/l

4.0

0.11

3494

31737

(3021601) Nitrite [Presence] in Urine by Test strip

1996

15535

1.62

43.72

6.8

5.2

estimate

0.0

0.50

251

2935

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

552

2999

1.99

43.64

3.0

2.4

u/l

74.2

39.0

0.47

494

2555

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

639

3666

1.90

42.92

3.1

2.7

umol/l

7.7

9.0

1.09

562

3220

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

373

1762

2.24

42.58

1.6

1.7

g/l

1.6

0.27

336

1508

(3003396) Base excess in Arterial blood by calculation

709

4238

1.83

41.72

7.8

6.9

mmol/l

0.9

1.1

0.84

564

3288

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

449

2301

2.08

41.61

9.6

8.4

0.7

0.70

449

2283

(3022096) Basophils/100 leukocytes in Blood

1872

14469

1.59

41.23

7.1

6.0

0.7

0.77

1764

13402

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1459

10630

1.61

41.18

2.5

2.2

u/l

194.5

207.2

0.25

1376

9898

(3027801) Oxygen [Partial pressure] in Arterial blood

705

4245

1.82

40.36

7.9

6.9

kpa

12.1

0.01

675

4044

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

705

4245

1.82

40.36

7.9

6.9

kpa

5.1

0.23

679

4044

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2749

23377

1.68

40.33

4.7

4.0

pmol/l

15.0

0.01

2518

20877

(3019150) Specific gravity of Urine by Refractometry

1025

6861

1.68

40.32

6.1

4.4

kg/l

1.0

0.53

174

1058

(3015377) Calcium [Moles/volume] in Serum or Plasma

1576

11765

1.59

39.75

3.6

3.5

mmol/l

2.4

0.42

1369

10099

(3000991) Gas panel - Venous blood

533

2958

1.94

39.32

9.4

8.0

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3536

32710

2.80

39.26

15.6

11.4

u/l

24.8

25.4

1.19

3462

31357

(36660697) Celiac disease serology panel - Serum

422

2169

2.07

38.67

1.2

—

(3016502) Oxygen saturation in Arterial blood

642

3821

1.82

37.97

8.3

7.2

96.2

95.5

3.68

627

3673

(3022217) INR in Platelet poor plasma by Coagulation assay

788

4984

1.74

37.84

33.4

27.6

inr

1.5

1.4

0.57

702

(3021960) Folate [Moles/volume] in Serum or Plasma

1207

8547

1.61

37.43

1.7

1.6

nmol/l

19.9

20.5

0.66

1067

7194

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1006

6825

1.65

37.01

2.0

1.7

mg/l

1.4

0.07

795

5318

(3020564) Creatinine [Moles/volume] in Serum or Plasma

3529

32720

2.67

37.00

28.8

19.5

umol/l

86.5

80.9

8.37

3529

32710

(3002173) Hemoglobin [Mass/volume] in Arterial blood

595

3499

1.83

36.47

8.7

7.7

g/l

116.7

120.6

5.43

580

3371

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

979

6623

1.65

36.31

3.3

3.1

mmol/l

2.5

0.74

872

5824

(3003458) Phosphate [Moles/volume] in Serum or Plasma

729

4615

1.72

34.52

6.9

5.8

mmol/l

1.1

1.0

1.98

676

4277

(3026493) Urate [Moles/volume] in Serum or Plasma

1227

8869

1.57

34.16

3.3

2.8

umol/l

6508.5

5857.0

0.17

1077

7510

(3007461) Platelets [#/volume] in Blood

3580

33567

3.00

34.14

37.1

24.2

e9/l

242.9

244.4

0.72

3526

32613

(3024731) MCV [Entitic volume]

3580

33571

3.00

34.05

37.0

24.2

91.7

91.6

0.73

3555

33005

(3018095) Leukocytes [#/volume] in Urine

1558

11885

1.54

34.01

4.7

3.9

e6/l

60.2

116.6

3.80

1156

8604

(3026361) Erythrocytes [#/volume] in Blood

3580

33573

3.00

34.01

37.2

24.2

e12/l

4.3

4.4

18.54

3520

32490

(3000963) Hemoglobin [Mass/volume] in Blood

3580

33579

2.99

33.88

37.4

24.4

g/l

130.7

133.9

30.11

3555

33019

(3035941) MCH [Entitic mass]

3579

33571

2.97

33.75

37.0

24.1

30.4

1.32

3554

33005

(3010813) Leukocytes [#/volume] in Blood

3579

33578

2.97

33.60

37.2

24.3

e9/l

6.9

6.8

1.16

3519

32492

(3030467) Casts [#/volume] in Urine by Automated count

1299

9567

1.55

33.02

3.8

3.2

e6/l

0.4

0.5

0.54

1042

7252

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

3242

29321

1.85

33.00

20.8

15.6

ml/min/173m2

73.6

75.1

4.00

2804

24306

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

825

5476

1.65

32.43

3.5

3.1

e6/l

2.1

2.2

0.12

510

3000

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

279

1307

2.23

32.28

2.9

u/ml

0.3

0.01

168

750

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

244

1081

2.35

32.21

1.3

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

3338

30520

1.95

32.14

5.9

5.1

mmol/l

6.1

2.82

3096

27330

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

692

4407

1.70

31.78

11.2

7.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

353

1827

2.03

31.50

1.7

1.9

g/l

1.6

1.4

0.44

323

1650

(3007853) Bacteria identified in Skin by Aerobe culture

616

3815

1.74

31.27

2.0

1.8

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

3232

29315

1.81

31.04

7.9

6.4

mmol/mol

41.3

40.6

3.90

3035

26709

(3037522) Nuclear Ab [Titer] in Serum

626

3904

1.73

30.97

1.4

1.3

titre

650.3

526.5

0.72

147

848

(3026008) Bacteria identified in Urine by Culture

1411

10694

1.52

30.86

3.8

3.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

420

2326

1.91

30.77

2.6

2.7

g/l

10.8

10.5

0.40

382

2116

(3013512) EKG study

1378

10408

1.52

30.55

5.1

4.3

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1688

13312

1.49

30.25

2.5

2.2

nmol/l

80.0

79.3

0.50

1508

11682

(3020630) Protein [Mass/volume] in Serum or Plasma

529

3187

1.77

29.45

2.8

2.6

g/l

65.9

66.2

0.48

488

2905

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

360

1932

1.96

28.90

9.7

8.8

mmol/l

24.2

24.3

0.39

333

1801

(3042936) Bacteria identified in Isolate by Culture

731

4840

1.64

28.58

2.1

2.0

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

858

5910

1.59

28.47

2.1

1.8

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1917

15623

1.47

28.42

2.7

2.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

470

2764

1.80

28.33

4.0

3.0

kpa

4.3

4.5

1.08

457

2679

(3021447) Carbon dioxide [Partial pressure] in Venous blood

548

3371

1.73

28.28

4.8

3.7

kpa

5.8

0.00

536

3276

(3013139) Helicobacter pylori Ag [Presence] in Stool

383

2115

1.90

28.21

1.3

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

534

3268

1.74

28.05

2.8

2.4

ug/l

5.8

7.1

1.40

471

2841

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

3202

29156

1.73

27.82

4.8

4.3

mmol/l

1.3

2.93

2935

26034

(36304419) Bacteria [Presence] in Urine

1226

9189

1.50

27.47

3.8

3.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

203

891

2.35

27.35

1.3

1.2

—

(3020779) Urea [Moles/volume] in Serum or Plasma

531

3277

1.72

27.00

9.7

7.1

mmol/l

11.1

10.6

0.88

507

3113

(42529406) Shigella sp [Presence] in Stool by Culture

203

898

2.33

26.86

1.3

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

200

881

2.34

26.72

1.3

1.2

—

(3002032) Base excess in Venous blood by calculation

541

3365

1.71

26.71

4.8

3.7

mmol/l

1.8

2.0

0.81

452

2736

(3025941) Bacteria identified in Stool by Culture

305

1590

2.00

26.56

1.5

1.3

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

463

2765

1.77

26.40

4.4

3.8

ng/l

102.3

94.9

0.80

398

2334

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

3364

31173

1.86

26.18

6.1

5.4

mmol/l

2.5

2.6

9.47

3127

28188

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

273

1378

2.06

25.98

5.1

4.0

mmol/l

24.6

24.8

0.50

255

1260

(3020891) Body temperature

285

1466

2.02

25.75

6.0

4.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

269

1357

2.06

25.64

3.6

3.3

u/ml

546.1

4012.4

0.97

237

1147

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

3297

30420

1.76

25.33

5.4

4.8

mmol/l

4.4

4.5

6.33

3071

27649

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

316

1702

1.94

25.01

3.2

2.6

1.1

1.2

0.22

316

1690

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1287

9884

1.46

24.91

3.8

3.2

u/l

35.1

38.1

0.40

1208

9340

(3009542) Hematocrit [Volume Fraction] of Blood

2968

26731

1.56

24.50

25.1

17.9

37.7

38.9

6.60

1907

17152

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

257

1297

2.05

24.46

1.0

1.1

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

3269

30147

1.72

24.41

5.3

4.8

mmol/l

1.5

0.66

3027

27181

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

207

3.73

24.28

1.2

1.1

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

308

1666

1.93

24.05

3.3

2.6

0.7

0.61

296

1593

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

451

2746

1.73

23.91

2.8

2.7

ml/min/173m2

58.6

61.9

1.18

199

1165

(3018677) aPTT in Platelet poor plasma by Coagulation assay

785

5487

1.55

23.86

2.4

2.0

30.1

29.9

0.31

772

5315

(3037121) Protein [Mass/volume] in Urine

241

1206

2.07

23.46

3.5

3.0

g/l

0.3

0.34

112

483

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1486

11830

1.43

23.27

5.7

4.2

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

435

2643

1.73

23.20

1.6

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

175

776

2.32

23.03

1.2

titre

136.7

88.5

0.46

(3022313) Gas panel - Capillary blood

298

1628

1.90

22.56

5.0

3.9

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

273

1449

1.95

22.52

1.6

1.5

u/ml

4.5

18.7

—

(3002582) Erythrocytes [#/volume] in Urine

1328

10406

1.43

22.49

4.0

3.4

e6/l

98.9

76.6

0.15

1058

8057

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

171

763

2.30

22.19

1.5

1.4

—

(3034770) Mitochondria Ab [Titer] in Serum

175

789

2.28

22.16

1.2

titre

1000.0

1028.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

238

1213

2.03

22.03

1.4

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

433

2677

1.70

21.61

2.8

2.4

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

192

909

2.17

21.58

1.9

1.4

iu/ml

15.0

19.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

378

2257

1.75

21.38

1.9

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

449

2817

1.68

21.18

1.5

—

(3018418) pH of Serum or Plasma

1321

10468

1.41

20.49

5.3

4.1

7.4

0.30

176

1991

(3000850) Epithelial cells [#/volume] in Urine

979

7361

1.45

20.31

2.8

2.7

e6/l

4.3

5.1

1.54

833

6455

(3019060) Gas panel - Arterial blood

404

2500

1.69

20.03

5.1

4.7

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

790

5715

1.49

19.94

3.6

3.1

mmol/l

0.8

1.07

748

5297

(3029937) Albumin [Presence] in Urine by Test strip

1108

8551

1.42

19.84

5.9

4.4

estimate

0.0

0.88

236

2803

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

602

4120

1.55

19.74

1.9

1.8

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

234

1247

1.94

19.06

2.3

2.2

ug/l

405.7

646.0

0.71

223

1181

(3044889) 12 lead EKG panel

2572

22904

1.40

19.04

5.0

4.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

357

2171

1.71

18.84

4.6

3.6

mmol/l

1.2

1.9

2.76

276

1588

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

594

4099

1.53

18.68

2.0

1.8

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

341

2065

1.72

18.26

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

170

3.57

18.16

1.5

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1399

11368

1.37

18.01

4.3

4.0

mg/mmol

13.9

9.4

2.10

947

7111

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

288

1670

1.79

17.95

5.2

4.0

47.5

47.6

0.03

288

1651

(3024522) Salmonella sp identified in Specimen by Organism specific culture

111

449

2.52

17.94

1.7

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

110

444

2.52

17.86

1.7

1.4

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

200

1033

1.99

17.84

1.6

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

110

445

2.52

17.78

1.7

1.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

173

3.51

17.70

1.5

1.2

—

(3009343) pH of Capillary blood

363

2255

1.68

17.67

4.7

3.7

7.4

0.29

285

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

111

454

2.49

17.54

1.7

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

110

448

2.50

17.53

1.7

1.4

—

(3043409) Potassium [Moles/volume] in Arterial blood

212

1126

1.94

17.44

5.4

3.8

mmol/l

3.8

3.9

1.86

206

1046

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

179

898

2.04

17.32

1.6

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

109

445

2.49

17.29

1.7

1.4

—

(3021589) Normoblasts [#/volume] in Blood

1663

13945

1.35

17.23

12.0

10.2

e9/l

0.0

1.04

1385

11370

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

365

2286

1.66

17.21

4.8

3.7

kpa

5.1

5.2

0.08

344

2112

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

261

1490

1.81

17.13

2.8

2.3

g/l

3.6

3.8

2.17

185

1068

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

261

1492

1.81

17.06

2.8

2.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

261

1493

1.80

17.02

2.8

2.3

g/l

7.4

7.5

0.19

195

1110

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

246

1385

1.83

16.90

2.6

2.4

g/l

3.0

3.1

0.31

191

1093

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

282

1666

1.75

16.47

4.7

4.0

mmol/l

23.8

24.2

1.01

256

1489

(46235355) HIV 1 and 2 tests - Meaningful Use set

477

3225

1.55

16.32

1.6

1.5

—

(3023183) Ammonium ion [Moles/volume] in Plasma

152

734

2.12

16.29

2.9

2.6

umol/l

35.3

34.9

0.06

126

618

(3026782) Osmolality of Urine

895

6855

1.40

16.13

3.3

2.8

mosm/kgh2o

540.2

546.2

0.37

756

5828

(4010399)

369

2355

1.63

16.13

1.5

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

688

5033

1.45

16.00

1.3

iu/ml

37.5

38.2

0.04

225

1554

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

209

1140

1.88

15.87

1.5

titre

110.0

265.2

1.19

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

225

1268

1.82

15.41

2.8

2.4

g/l

1.1

1.0

0.07

197

1095

(3002256) Pathology report gross observation

614

4426

1.46

15.37

1.4

1.3

—

(4035726)

457

3102

1.54

15.31

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

104

440

2.40

15.31

1.8

1.6

g/l

0.7

0.9

0.57

336

(3003338) MCHC [Mass/volume]

2701

24579

1.37

15.19

32.6

21.8

g/l

330.5

331.7

9.68

2689

24400

(3009508) Creatinine [Moles/volume] in Urine

1336

10991

1.34

15.12

3.5

3.2

mmol/l

7.1

7.2

0.27

1134

9086

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

222

1254

1.82

15.09

3.7

3.3

mg/l

33.2

63.9

1.90

192

1021

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

319

1996

1.65

15.06

10.6

9.5

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

222

1256

1.82

15.02

3.7

3.3

mg/l

113.6

97.8

0.10

191

1019

(3019225) pH of Specimen

525

3689

1.49

14.91

5.5

4.5

—

(3012516) Albumin [Mass/volume] in Urine

1313

10792

1.34

14.89

3.6

3.3

mg/l

271.0

321.3

0.21

875

6763

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

240

1395

1.77

14.83

2.8

2.3

g/l

10.0

10.2

0.24

203

1184

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

208

1159

1.84

14.78

2.6

2.2

g/l

37.4

37.5

0.11

175

997

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

244

2.86

14.57

1.3

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

241

2.86

14.31

1.3

1.4

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

215

1224

1.80

14.25

3.8

3.3

ratio

8.2

2.3

0.39

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

389

2.43

14.07

1.1

g/l

1.5

0.05

345

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

410

2775

1.54

13.87

1.8

1.7

1.6

0.88

343

2351

(3000494) Fungus identified in Specimen by Culture

529

3778

1.47

13.79

1.6

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

198

1112

1.82

13.73

2.8

2.3

g/l

0.0

0.28

183

1021

(3008152) Bicarbonate [Moles/volume] in Arterial blood

358

2356

1.58

13.72

8.2

6.7

mmol/l

24.7

24.6

0.48

344

2192

(3028192) IgG subclass 2 [Mass/volume] in Serum

277

2.67

13.52

1.6

1.4

g/l

2.6

3.0

0.83

194

(3027135) IgG subclass 1 [Mass/volume] in Serum

277

2.67

13.52

1.6

1.4

g/l

6.7

7.1

0.49

196

(3024139) IgG subclass 3 [Mass/volume] in Serum

277

2.67

13.52

1.6

1.4

g/l

0.4

0.34

196

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

643

4781

1.42

13.46

1.3

1.2

u/ml

9.1

14.9

1.05

227

1731

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

186

1035

1.84

13.29

2.8

2.3

g/l

0.0

0.50

171

949

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

186

3.04

13.24

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

186

3.04

13.24

1.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

421

2894

1.51

13.23

2.3

2.2

nmol/l

373.9

374.1

0.01

388

2626

(40760892) CBC W Ordered Manual Differential panel - Blood

834

6495

1.37

13.21

5.3

4.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

172

938

1.87

13.10

3.5

3.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

126

620

2.07

12.91

6.0

5.2

iu/ml

576.1

3187.9

0.51

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

431

2.28

12.83

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

253

1565

1.66

12.48

2.2

1.9

ug/l

1.3

2.5

1.79

229

1370

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

181

1019

1.82

12.47

2.8

2.3

g/l

0.0

0.00

170

948

(3005570) Glucose [Moles/volume] in Urine

321

2.46

12.27

2.0

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

162

888

1.86

12.17

2.4

2.3

g/l

3.7

3.6

0.16

153

840

(4062490)

282

2.55

12.04

1.6

1.4

—

(3036489) Thrombin time

193

1136

1.74

11.45

2.0

1.9

22.3

21.6

0.39

177

1017

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

486

3543

1.43

11.23

1.3

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

148

811

1.86

11.15

3.3

3.2

u/ml

70.8

732.8

1.36

135

741

(3006462) Nitrate [Presence] in Urine

167

2.96

11.13

5.3

4.0

—

(3000492) Spirometry study

378

2644

1.48

10.86

1.5

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

863

6928

1.32

10.86

5.0

4.0

ng/l

198.6

504.4

1.36

737

5824

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

128

675

1.93

10.85

1.3

—

(3006270) Folate [Moles/volume] in Blood

303

2.40

10.83

1.3

1.2

nmol/l

331.9

355.5

0.45

246

(3021879) Hepatitis B virus core Ab [Presence] in Serum

261

1686

1.59

10.82

1.4

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

580

4387

1.38

10.80

4.9

4.8

32.9

33.2

0.27

430

2827

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

129

684

1.92

10.76

1.3

1.2

titre

56.0

238.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

406

2.20

10.70

1.9

2.0

—

(3049717) Cytology report of Urine Cyto stain

240

1525

1.61

10.66

2.9

2.6

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

150

843

1.81

10.44

3.4

3.2

nmol/l

0.8

0.90

127

638

(4211845)

181

2.79

10.21

5.2

3.9

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

331

2.29

10.16

1.5

1.6

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

222

2.59

10.11

1.1

1.2

titre

105.7

110.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

204

1265

1.65

10.00

2.6

2.7

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

276

1841

1.54

9.95

1.4

1.3

au/ml

49.4

56.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

400

2.15

9.87

1.3

nmol/l

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

454

2.08

9.82

1.3

nmol/l

0.7

0.04

432

(3003694) ABO and Rh group [Type] in Blood

958

7899

1.29

9.71

1.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

352

2.21

9.61

1.5

1.6

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

154

895

1.75

9.60

2.2

2.1

91.3

89.8

0.35

147

851

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

183

1121

1.67

9.42

1.1

u/ml

0.9

1.3

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

144

826

1.77

9.40

2.3

208.8

203.0

0.29

138

787

(3004616) Nuclear Ab [Presence] in Serum

377

2.15

9.28

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1434

12458

1.25

9.25

6.1

5.4

ug/l

4.6

3.8

0.13

1306

11090

(3045414) Leukocytes [Presence] in Urine

230

1498

1.57

9.23

2.0

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

295

2034

1.49

9.10

2.6

2.4

au/ml

28.7

24.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

230

1506

1.56

9.02

2.2

1.9

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

107

567

1.91

9.00

1.4

—

(3002385) Erythrocyte distribution width [Ratio]

2660

24766

1.26

9.00

28.4

20.1

14.1

13.8

14.13

2622

24203

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

456

2.02

8.99

1.3

nmol/l

0.1

0.3

—

(3045424) Erythrocytes [Presence] in Urine

107

568

1.91

8.96

1.7

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

240

1593

1.54

8.86

1.5

1.3

u/ml

170.8

204.3

0.56

218

1453

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

148

874

1.72

8.75

1.6

iu/ml

0.1

11.5

0.92

187

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

475

1.98

8.72

3.1

2.1

mg/l

20.7

24.4

0.31

115

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

913

7577

1.27

8.62

1.8

1.7

pmol/l

81028095.7

28163032.9

1.00

759

6150

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

102

541

1.91

8.58

1.4

1.3

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

123

693

1.80

8.55

1.1

u/ml

5.8

6.8

—

(3037756) Immunofixation for Serum or Plasma

141

828

1.73

8.51

1.6

—

(3044927) Protein electrophoresis panel - Urine

406

2.04

8.39

1.3

1.2

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

104

560

1.88

8.36

1.3

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

173

2.62

8.26

2.3

2.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

416

2.02

8.23

1.3

—

(3011985) Renin [Units/volume] in Plasma

437

1.99

8.21

1.5

1.3

mu/l

82.8

61.6

0.29

385

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

217

2.42

8.06

1.3

1.4

u/l

27.3

33.0

0.60

177

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

249

1704

1.49

7.98

3.0

3.3

pmol/l

4.4

0.07

221

1478

(21494434) Karyotype in Bone marrow

348

2.09

7.88

1.1

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

348

2.09

7.88

1.1

1.2

u/l

53.8

57.5

0.21

238

(3038177) Helicobacter pylori Ab [Presence] in Serum

382

2.04

7.87

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

349

2.08

7.83

3.4

2.9

—

(3000475) Leukocytes [#/volume] in Synovial fluid

141

850

1.68

7.77

1.6

e6/l

13137.5

13291.8

0.01

602

(44816559) Phosphatidylethanol [Mass/volume] in Blood

454

1.94

7.72

1.5

1.3

—

(40768441) Liver Pathology biopsy report

211

2.39

7.59

1.6

1.4

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

209

1395

1.53

7.56

2.0

1.8

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

153

950

1.64

7.53

1.5

1.4

—

(40768443) Skin Pathology biopsy report

221

1499

1.50

7.41

1.3

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

437

3355

1.34

7.28

3.2

3.0

ng/l

239.9

211.8

0.62

400

3083

(3048929) Epstein Barr virus Ab [Presence] in Serum

109

623

1.77

7.28

1.2

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

332

2.07

7.28

2.5

2.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

173

1119

1.57

7.21

1.2

u/ml

0.2

1.5

2.35

110

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

121

716

1.71

7.16

1.4

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

115

673

1.73

7.09

1.4

1.6

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

468

1.88

7.08

1.4

u/ml

114.3

121.1

0.23

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

125

751

1.69

7.01

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

125

751

1.69

7.01

1.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

136

2.66

6.89

34.6

25.7

ug/l

123.3

114.6

0.33

113

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

288

2.10

6.74

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

288

2.10

6.74

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

288

2.10

6.74

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

483

1.84

6.74

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

406

1.92

6.68

1.2

1.3

pmol/l

267.5

274.0

0.08

309

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

844

7123

1.24

6.66

3.2

ug/l

0.8

0.08

655

5076

(3026389) Candida sp identified in Specimen by Organism specific culture

435

1.88

6.65

1.5

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

354

1.97

6.49

1.9

1.6

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

490

1.82

6.45

2.7

2.5

u/ml

319.9

1945.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

335

1.99

6.40

1.2

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1145

10003

1.21

6.39

5.1

4.7

22.3

22.0

0.29

637

5252

(40757494) Bilirubin.total [Moles/volume] in Blood

205

2.26

6.23

3.0

2.1

umol/l

15.5

25.9

—

(3017704) Immunofixation for Urine

212

2.23

6.19

1.4

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

446

1.83

6.18

1.2

u/ml

274.3

294.3

0.22

264

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

101

594

1.72

6.17

1.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

134

2.55

6.02

2.3

2.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

450

1.82

6.01

2.1

1.6

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

215

2.20

6.00

1.0

mg/l

285.2

288.8

0.13

186

(3051593) INR in Capillary blood by Coagulation assay

196

2.26

5.98

8.8

13.5

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

127

801

1.61

5.95

1.2

u/ml

33.6

43.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

285

2126

1.37

5.74

2.4

2.1

nmol/l

11.7

12.1

0.29

241

1821

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

300

1.98

5.73

1.6

1.5

u/ml

22.1

22.7

0.06

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.92

5.71

1.9

2.2

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

480

1.77

5.70

1.4

1.5

—

(3017732) Neutrophils [#/volume] in Blood

283

2114

1.37

5.65

3.6

3.2

e9/l

4.0

4.2

0.45

198

1540

(3033705) Calcium.ionized [Moles/volume] in Venous blood

469

1.77

5.56

2.5

2.3

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

130

839

1.57

5.55

2.9

2.8

mg/l

1.9

1.7

1.97

116

751

(3052851) Hemolysis interference index of Serum or Plasma

154

1035

1.51

5.48

4.1

3.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

399

1.82

5.42

4.2

4.1

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

123

790

1.58

5.37

1.8

1.9

mg/l

12.7

12.1

0.37

112

721

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

101

618

1.65

5.37

1.3

1.2

u/l

30.4

43.9

0.93

531

(44790049)

367

1.84

5.25

1.5

1.4

—

(44806118)

367

1.84

5.25

1.5

1.4

—

(44790048)

367

1.84

5.25

1.5

1.4

—

(44790047)

367

1.84

5.25

1.5

1.4

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

124

803

1.56

5.24

1.6

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

382

1.82

5.23

3.6

55.4

57.9

0.37

231

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

126

822

1.55

5.16

1.6

1.5

—

(3041354) Potassium [Moles/volume] in Venous blood

481

1.72

5.12

2.5

2.3

mmol/l

4.1

0.23

474

(3035285) Chloride [Moles/volume] in Venous blood

481

1.72

5.12

2.5

2.3

mmol/l

106.0

105.3

0.85

474

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

3.76

5.08

1.8

2.3

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

374

1.81

4.96

3.8

3.6

—

(4015189)

105

2.58

4.96

2.4

2.1

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

115

745

1.56

4.87

1.2

u/ml

1.9

3.3

0.98

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

451

1.72

4.85

1.9

pmol/l

180.1

197.6

0.81

420

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

134

900

1.51

4.82

1.4

1.7

—

(3004809) Band form neutrophils/100 leukocytes in Blood

613

1.61

4.82

3.4

3.7

1.9

1.6

0.31

466

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

483

1.69

4.79

6.6

6.5

mg/l

12.5

12.1

0.36

446

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

250

1.97

4.78

1.4

titre

281.7

426.5

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

138

2.33

4.75

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

617

1.60

4.70

1.6

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.65

4.65

1.1

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

526

1.65

4.63

1.3

1.4

—

(4146454)

420

1.73

4.62

2.5

2.6

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

115

755

1.54

4.61

1.2

u/ml

5.5

8.2

0.30

129

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

398

1.75

4.61

1.2

u/ml

4.6

5.0

0.09

168

(3047189) Immunofixation for 24 hour Urine

186

2.11

4.57

1.3

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

467

1.68

4.56

1.4

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

160

2.20

4.55

1.0

1.1

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.60

4.48

1.0

1.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

3.42

4.46

1.3

1.5

umol/l

43.3

42.7

0.03

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

182

1319

1.40

4.42

1.7

1.8

u/l

39.8

38.5

0.38

164

1131

(3045142) Bone marrow Pathology biopsy report

426

1.70

4.41

1.3

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

105

684

1.55

4.38

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

210

2.01

4.36

1.5

1.6

u/l

4.2

6.6

0.42

104

(3030981) Hyaline casts [#/volume] in Urine by Automated count

245

1870

1.33

4.30

3.1

2.9

e6/l

0.2

0.3

0.56

237

1829

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

184

2.08

4.30

2.0

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

441

3639

1.24

4.19

1.4

—

(4094501)

129

887

1.47

4.19

1.1

—

(3042631) Mycobacterium sp identified in Specimen

511

1.62

4.14

2.5

2.9

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

442

1.66

4.13

1.1

1.0

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

404

1.70

4.13

1.2

u/ml

2.8

3.6

0.30

118

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

257

1.88

4.11

1.1

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

647

1.54

4.10

1.2

—

7.0

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

338

1.76

4.07

1.5

1.4

e6/l

124869.5

118873.0

0.03

234

(3026250) Tacrolimus [Mass/volume] in Blood

111

2.35

3.99

28.5

31.4

ug/l

7.1

7.2

0.09

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

184

2.02

3.93

2.7

2.0

e6/l

386.6

494.1

0.85

159

(3026692) Albumin [Mass/volume] in Peritoneal fluid

2.46

3.88

1.6

1.5

g/l

12.9

14.4

0.35

(3051611) Lipemic interference index of Serum or Plasma

368

1.70

3.80

3.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

229

1.89

3.77

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

487

1.59

3.70

1.2

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

267

1.81

3.69

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

353

2884

1.25

3.68

4.2

4.1

1.2

0.9

1.24

134

849

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

3.01

3.68

1.1

1.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

551

1.56

3.68

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

380

1.67

3.66

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

176

2.00

3.63

2.8

2.1

e9/l

0.2

0.10

158

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

129

915

1.42

3.60

2.7

2.3

ug/min

173.6

94.2

0.97

544

(3024928) Oxygen saturation in Venous blood

111

766

1.46

3.59

3.8

2.9

—

(3036603) Volume of Urine

220

1.87

3.54

1.4

1.6

1890.4

1707.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

301

1.74

3.51

1.0

u/ml

2.9

2.2

0.31

(43055514) Macroprolactin [Presence] in Serum or Plasma

3.56

3.48

2.6

1.3

—

(3021788) Differential panel - Synovial fluid

624

1.50

3.46

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

115

808

1.44

3.40

1.6

1.5

—

(4281824)

342

1.68

3.40

1.3

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

201

1552

1.31

3.32

5.4

5.3

0.9

0.12

196

1456

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

128

2.12

3.29

2.4

89.7

98.8

0.65

120

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.54

3.29

1.1

1.2

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

190

1.90

3.28

1.3

1.4

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

190

1.90

3.28

1.3

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

455

1.57

3.27

1.4

1.2

miu/ml

278.4

195.8

0.87

172

(3022689) Creatine [Moles/volume] in Urine

2.34

3.24

1.4

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

2.51

3.20

1.9

1.6

—

(21494815) CD4 cells/100 lymphocytes in Specimen

229

1.80

3.15

1.6

1.9

40.0

45.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

460

1.55

3.14

1.1

1.0

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

172

1.93

3.13

2.2

1.6

u/field

0.6

2.5

4.05

121

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

195

1515

1.30

3.10

4.0

u/ml

81.1

64.4

0.23

187

1458

(3023420) DNA double strand Ab [Units/volume] in Serum

290

1.70

3.10

1.4

1.3

—

26.0

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

187

1.88

3.10

1.6

1.5

u/l

10.8

6.1

0.43

158

(3017315) Amylase [Enzymatic activity/volume] in Urine

159

1.96

3.09

1.1

1.2

u/l

193.3

346.6

1.08

147

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

201

1570

1.30

3.07

5.4

5.3

1.6

0.05

196

1468

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

195

1.85

3.06

2.3

1.9

e6/l

584.9

638.8

0.25

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

488

1.53

3.03

1.5

1.6

—

(3011412) CD3 cells [#/volume] in Blood

277

1.71

3.03

2.6

2.0

e9/l

0.9

1.1

0.62

166

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

2.27

3.03

6.9

6.6

59.0

73.8

1.22

(3032057) Clostridioides difficile [Presence] in Stool

2.31

3.00

1.8

2.0

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

263

1.72

2.99

1.8

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

131

968

1.37

2.94

5.9

4.5

—

(1002224) Polysomnography panel

123

902

1.38

2.90

1.0

1.1

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

170

1.89

2.90

1.1

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

575

1.47

2.90

3.4

3.2

—

(3011648) Oxygen content in Venous blood

281

1.68

2.89

2.0

1.9

10.0

10.9

0.69

281

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

2.38

2.89

1.3

2.7

190.7

193.5

0.04

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

360

3032

1.21

2.85

1.6

—

(3042733) HLA Ab [Presence] in Serum

2.34

2.81

4.4

5.1

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

654

1.43

2.80

1.3

1.5

nmol/l

0.9

0.8

0.26

541

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

181

1.83

2.73

2.8

2.5

38.5

37.9

0.06

(1761868) Lipid panel - Serum or Plasma

851

9373

0.88

2.71

3.3

3.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

105

2.10

2.68

3.0

mu/l

24.5

22.3

0.12

100

(3019768) Coxiella burnetii Ab [Presence] in Serum

4.22

2.67

2.1

1.4

—

(3000330) Specific gravity of Urine by Test strip

226

1829

1.25

2.63

4.7

3.6

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

111

815

1.37

2.63

1.7

2.2

g/l

124.0

128.2

0.83

592

(3002179) Metamyelocytes/100 leukocytes in Blood

312

2614

1.21

2.62

4.0

3.9

0.7

0.6

0.22

101

590

(40768446) Kidney Pathology biopsy report

113

2.04

2.61

1.5

1.6

—

(4268621)

275

1.64

2.58

2.4

2.3

—

(3032773) Endomysium IgG Ab [Titer] in Serum

207

1.75

2.57

1.1

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

107

2.06

2.57

2.0

e6/l

3240.1

26166.6

0.73

(3009214) Lutropin [Units/volume] in Serum or Plasma

500

1.47

2.55

1.3

u/l

13.1

11.2

0.44

399

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.51

2.53

1.5

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

246

1.67

2.52

1.5

1.7

u/l

399.5

2381.6

1.14

(3021440) Promyelocytes/100 leukocytes in Blood

324

2738

1.20

2.50

4.3

4.1

0.2

0.1

0.52

117

789

(3003181) Sodium [Moles/volume] in Urine

679

1.39

2.48

1.3

mmol/l

56.4

61.7

0.96

553

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

2.83

2.47

1.1

58.7

75.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

133

1015

1.32

2.47

1.7

1.5

—

(3023419) Bacteria identified in Sputum by Culture

479

1.47

2.47

2.9

2.5

—

(3004451) EKG impression Narrative

189

1.75

2.41

1.2

1.3

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

204

1.72

2.40

2.3

1.9

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

131

1.91

2.40

3.0

2.5

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

2.76

2.37

1.1

77.8

77.5

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

2.51

2.35

1.1

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

133

1.89

2.31

1.8

1.7

—

(3020491) Glucose [Moles/volume] in Blood

245

1.64

2.31

1.5

2.1

mmol/l

8.0

6.9

1.20

164

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

200

1.71

2.28

1.2

1.4

nmol/l

0.2

0.3

0.32

149

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

141

1.85

2.27

1.1

1.2

—

(3020393) Adenovirus Ag [Presence] in Stool

3.48

2.27

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

5.56

2.21

1.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

5.56

2.21

2.0

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

5.56

2.21

1.0

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.20

1.1

1.0

—

(3033799) Differential panel - Peritoneal fluid

107

1.97

2.20

2.8

1.9

—

(3011544) Albumin [Mass/volume] in Pleural fluid

2.78

2.20

1.1

g/l

18.4

16.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

180

1.73

2.18

1.1

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.50

2.18

1.1

—

(3003129) Base excess in Capillary blood by calculation

2.03

2.15

2.3

2.0

mmol/l

-0.4

0.8

0.54

(3003434) Protein [Mass/volume] in Pleural fluid

570

1.39

2.14

1.6

1.5

g/l

29.5

32.3

1.16

514

(3044941) Cell count panel - Synovial fluid

562

1.40

2.13

1.3

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

420

1.46

2.13

4.0

4.6

umol/l

343.2

345.8

0.05

363

(4306422)

381

1.48

2.08

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

131

1.84

2.07

1.8

1.7

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

131

1.84

2.07

1.8

1.7

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

131

1.84

2.07

1.3

1.7

nmol/l

1.3

9.0

1.45

110

(3025159) Blasts/100 leukocytes in Blood

300

2565

1.18

2.07

4.4

4.1

0.1

0.4

0.82

102

659

(3023487) Leukocytes [#/volume] in Peritoneal fluid

124

1.86

2.06

2.5

2.2

e6/l

1427.6

871.9

0.29

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

3.50

2.05

1.4

1.2

—

(3028433) Virus identified in Specimen by Culture

110

1.91

2.05

1.0

1.2

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.18

2.04

1.1

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

142

1130

1.27

1.98

1.8

1.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

647

1.35

1.98

1.2

1.1

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

3.34

1.96

1.1

1.0

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

4.55

1.94

1.0

1.2

nmol/l

187.8

288.9

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

187

1.66

1.93

1.3

u/ml

1.0

1.2

0.07

(3050794) Legionella sp Ab [Presence] in Serum

2.97

1.93

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

120

1.84

1.92

1.1

1.0

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

274

1.54

1.92

1.8

2.0

u/field

4.7

1.8

0.87

(3048879) Bone marrow aspiration report

113

1.86

1.91

1.8

1.5

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

106

1.89

1.90

1.3

2.4

189.0

168.2

0.46

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

106

819

1.30

1.88

1.3

1.2

—

(3051651) Icteric interference index of Serum or Plasma

205

1.62

1.85

3.1

3.5

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

205

1.62

1.85

2.3

1.9

16.2

15.0

0.20

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

167

1.68

1.83

1.7

1.6

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

2.50

1.83

1.3

1.2

ug/l

110.4

122.6

—

(40761536) Microorganisms panel - Urine sediment

231

2718

0.84

1.83

5.2

4.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

130

1.77

1.81

1.0

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

199

1.61

1.80

2.2

2.0

ug/min

108.0

158.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.92

1.80

1.2

1.3

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.76

1.79

3.8

2.4

u/field

0.4

0.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

240

1.55

1.75

1.1

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

2.03

1.74

1.1

1.3

mu/l

22.4

61.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

170

1.65

1.73

1.0

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

933

8688

1.10

1.72

1.7

1.6

mmol/l

1.3

0.02

819

7165

(3035637) Corticotropin [Mass/volume] in Plasma

389

1.42

1.72

1.5

1.6

—

(3024932) HLA-DR beta [Type]

1.96

1.69

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

425

1.39

1.68

1.7

1.5

53.1

60.1

0.64

265

(3000034) Microalbumin [Mass/volume] in Urine

311

1.45

1.61

3.7

3.1

mg/l

21.9

33.1

0.59

242

(3044290) Cell count panel - Cerebral spinal fluid

610

1.32

1.60

1.3

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

320

1.44

1.59

1.4

1.3

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

1.95

1.59

1.1

1.2

umol/24h

0.9

0.7

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

124

1002

1.25

1.58

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

167

1.62

1.58

1.7

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

167

1.62

1.58

1.7

1.6

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

167

1.62

1.58

1.7

1.6

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

691

1.30

1.57

1.7

1.8

iu/l

2.7

4.5

3.56

225

(3022621) pH of Urine by Test strip

256

2218

1.17

1.56

3.6

3.2

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

1.85

1.55

1.5

1.6

ug/l

0.3

0.4

0.58

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

248

1.50

1.54

2.1

2.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

240

1.50

1.54

1.4

1.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

773

1.28

1.54

1.3

mg/l

773.9

559.0

0.36

722

(3026480) Teichoate Ab [Titer] in Serum

2.43

1.53

1.1

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.43

1.53

1.0

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

130

1.70

1.52

1.3

1.2

—

(3001729) Color of Synovial fluid

0.00

1.52

0.0

1.5

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

3.34

1.52

1.4

5.8

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.86

1.50

1.1

miu/ml

1687.7

1736.0

0.05

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

705

1.28

1.50

1.2

1.3

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

681

1.28

1.46

1.2

mmol/l

3.9

0.01

630

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

655

1.29

1.45

1.4

1.3

—

(3024471) HLA-A [Type]

1.84

1.45

1.0

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.84

1.45

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

3.13

1.44

1.0

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

125

1.68

1.43

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

1.97

1.43

1.9

1.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.31

1.43

1.0

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

172

1.57

1.42

1.8

1.5

g/l

0.9

1.0

1.05

172

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

172

1.57

1.42

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

172

1.57

1.42

1.0

—

(40768806) Pleura Pathology biopsy report

440

1.35

1.40

1.5

1.6

—

(3019977) pH of Arterial blood

213

1.51

1.40

1.9

2.6

7.4

0.25

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

304

1.42

1.40

1.0

1.1

u/ml

0.8

1.5

0.69

112

(3028308) Erythrocytes [#/volume] in Pleural fluid

458

1.34

1.39

1.5

1.4

e6/l

38747.3

77238.5

0.71

264

(3027231) Wheat IgE Ab [Units/volume] in Serum

2.42

1.39

1.0

—

(3016018) Differential panel - Cerebral spinal fluid

313

1.41

1.39

1.2

1.4

—

(3019832) Treponema pallidum Ab [Presence] in Serum

125

1029

1.22

1.38

1.5

1.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

322

1.40

1.37

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

119

1.68

1.37

1.4

1.2

ug/l

166.9

448.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

166

1.57

1.37

1.0

1.1

—

(3012441) Differential panel - Pleural fluid

435

1.34

1.6

1.5

—

(3035611) Eosinophils/100 leukocytes in Synovial fluid

0.00

1.34

0.0

1.6

—

0.7

—

(3023199) Leukocytes [#/volume] in Pleural fluid

505

1.31

1.33

1.6

1.4

e6/l

2969.9

1681.3

0.34

365

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.29

1.26

1.1

1.2

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

252

1.43

1.26

4.7

4.9

u/ml

19.9

51.7

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

138

1.60

1.26

9.9

5.8

mg/l

67.8

65.5

0.05

(3023511) Choriogonadotropin [Units/volume] in Urine

107

1.69

1.25

1.6

1.3

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

2.40

1.24

1.2

1.0

—

3.1

—

(3036670) Protein [Mass/volume] in Synovial fluid

123

1.63

1.23

1.3

1.2

g/l

37.8

39.3

0.12

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.86

1.23

1.2

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

2.63

1.21

1.0

—

(4212803)

2.11

1.18

1.0

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.00

1.16

10.6

13.7

mmol/l

4.6

5.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

240

1.42

1.15

1.6

1.3

—

(44813793)

174

1.50

1.15

1.2

1.1

—

(3004775) Volume in Urine collected for unspecified duration

300

1.37

1.14

2.6

2.2

754.2

626.6

0.77

186

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

1.14

0.0

1.1

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

268

2995

0.89

1.13

5.4

3.9

mmol/l

1.2

0.79

245

2618

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.85

1.13

1.3

1.8

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

626

1.25

1.13

1.5

pmol/l

211.0

232.7

0.12

610

(3016750) Collection duration of Urine

208

1.45

1.12

2.7

2.0

min

494.2

487.3

0.14

150

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.34

1.12

2.0

1.9

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

127

1.58

1.11

1.2

1.1

ng/l

780.9

367.7

—

(3014271) Vancomycin [Susceptibility]

217

1.43

1.11

2.6

2.9

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

2.26

1.10

2.1

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

2.26

1.10

2.1

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

2.26

1.10

2.1

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

168

1.49

1.09

2.1

1.8

—

9.9

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

2.38

1.09

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.95

1.08

2.0

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

514

1.27

1.08

1.1

—

(3025577) Chromium [Mass/volume] in Blood

261

1.38

1.07

2.2

2.1

ug/l

1.7

2.0

0.52

222

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

330

1.34

1.07

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.76

1.06

1.2

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

194

1.45

1.06

2.5

3.4

—

(4034850)

123

1043

1.19

1.05

13.4

11.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

113

1.60

1.05

1.6

2.4

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

113

1.60

1.05

1.6

2.4

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

178

1.46

1.05

6.2

6.4

—

(3008898) HLA-B27 [Presence]

724

1.22

1.04

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.27

1.03

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

2.27

1.03

1.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

1.96

1.03

1.6

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

106

1.61

1.02

11.9

11.6

mmol/l

0.6

0.05

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

255

1.38

1.02

1.1

—

(1616796) Gas panel - Central venous blood

817

1.20

1.02

3.6

4.0

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.92

1.02

1.1

1.0

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

1.77

1.00

1.4

1.5

8.9

5.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.65

1.00

2.9

2.1

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

2.00

1.00

8.0

5.1

ug/min

58.0

70.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.71

0.98

1.1

—

(3002619) Bacteria identified in Specimen by Culture

1.81

0.98

1.4

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

283

1.35

0.98

1.5

1.4

u/l

15.0

13.2

0.92

269

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.00

0.97

0.0

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.95

0.97

1.6

1.8

—

(3010421) pH of Blood

111

942

1.18

0.96

5.3

4.6

7.4

0.05

797

(3036071) Salmonella sp Ab [Titer] in Serum

1.69

0.95

1.2

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

141

1.49

0.94

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

158

1.46

0.93

1.5

1.4

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

627

1.22

0.90

4.1

3.6

59.9

58.1

0.68

627

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

402

1.27

0.90

1.5

1.6

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

186

1656

1.13

0.87

1.2

iu/ml

146.1

141.2

0.05

586

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.82

0.85

1.1

1.0

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

112

1.52

0.84

1.4

24.1

23.1

0.04

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

162

1.42

0.84

1.4

1.6

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

121

1.49

0.82

2.2

1.3

umol/l

21.9

29.9

2.25

116

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.74

0.82

2.3

1.1

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

381

1.26

0.82

1.4

u/l

249.9

327.2

0.89

366

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

214

1.36

0.82

1.1

1.2

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

163

1.41

0.82

1.0

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

1.88

0.81

1.5

1.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.58

0.81

1.9

1.5

ug/l

8.7

9.0

0.15

(3023383) Lactate [Moles/volume] in Pleural fluid

130

1.46

0.80

1.3

1.4

mmol/l

2.2

3.4

2.26

117

(3003888) Timothy IgE Ab [Units/volume] in Serum

268

1.31

0.79

1.0

u/ml

3.3

3.4

0.01

115

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.67

0.78

1.1

—

(3016879) Cocaine [Presence] in Urine

295

1.29

0.78

1.6

1.4

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

394

1.25

0.77

1.3

1.6

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

217

1.34

0.76

1.1

1.2

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

132

1.44

0.75

1.2

1.1

—

(3044007) Cell count panel - Peritoneal fluid

1.52

0.75

1.9

2.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

149

1.41

0.75

1.1

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

2.08

0.74

1.8

1.2

ml/s/173m2

0.7

0.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

116

1.47

0.74

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.84

0.73

2.1

1.7

—

(40768800) Prostate Pathology biopsy report

850

0.84

0.72

1.1

1.2

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

1.80

0.72

1.4

1.2

mg/l

3.9

7.4

—

(3016038) Potassium [Moles/volume] in Urine

246

1.30

0.72

1.2

1.1

mmol/l

36.4

34.3

0.21

211

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.75

0.71

1.1

1.2

umol/24h

2.2

1.8

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.92

0.70

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.92

0.70

1.0

—

(46235168) Fasting glucose [Moles/volume] in Blood

1.92

0.70

1.4

1.6

mmol/l

6.7

8.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.92

0.70

1.0

1.1

—

(3027944) Amphetamines [Presence] in Urine

309

1.26

0.70

1.5

1.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

109

954

1.15

0.70

3.3

3.2

mmol/l

24.3

25.0

0.99

102

827

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.71

0.70

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

118

1.44

0.69

1.4

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

391

1.23

0.69

1.1

—

(4198724)

1.67

0.68

1.3

1.4

—

(3001186) Copper [Moles/volume] in Serum or Plasma

1.53

0.68

1.0

1.1

umol/l

16.6

16.9

—

(21494755) Public health laboratory ask at order entry panel

120

1355

0.88

0.68

1.3

1.4

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

214

1.31

0.66

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

214

1.31

0.66

1.1

1.2

—

(3025315) Body weight

1.79

0.66

6.0

4.4

—

(3011288) Drugs identified in Urine by Screen method

206

1.31

0.65

1.9

1.8

—

(40762814) Titanium [Mass/volume] in Blood

1.57

0.65

2.5

2.2

ug/l

3.0

4.0

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

120

1.42

0.64

1.6

umol/l

77.8

126.7

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

260

1.27

0.64

1.0

1.1

u/ml

0.6

1.4

0.81

100

(3028707) Methadone [Presence] in Urine by Screen method

146

1.37

0.63

2.0

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

314

1.24

0.63

1.5

1.4

—

(3027008) Opiates [Presence] in Urine

314

1.24

0.63

1.5

1.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

156

1411

1.11

0.62

1.2

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

208

1.30

0.62

1.4

1.6

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1080

0.88

0.61

1.5

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

217

1.29

0.61

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

217

1.29

0.61

1.1

1.2

—

(3028300) Cannabinoids [Presence] in Urine

316

1.24

0.61

1.5

1.4

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.48

0.60

1.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

209

1.29

0.60

1.4

1.6

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

768

0.86

0.59

5.2

3.6

mg/l

29.4

28.5

0.06

485

(3050129) First trimester maternal screen panel - Serum or Plasma

114

1.41

0.58

1.4

1.5

—

(3012501) Base excess in Blood by calculation

809

1.14

0.58

5.1

4.8

mmol/l

3.2

2.7

0.61

568

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.46

0.58

1.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.72

0.57

2.2

1.9

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.67

0.56

1.7

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

194

1.29

0.55

1.2

1.6

—

(4024509)

375

1.20

0.55

1.6

—

(3041096) Erythrocytes [Presence] in Urine by Automated

838

8090

1.05

0.55

4.6

3.7

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.46

0.54

1.4

1.2

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

213

1.27

0.54

1.8

1.7

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

1.45

0.53

1.3

1.2

mg/l

0.8

78.8

—

(3035320) C reactive protein [Mass/volume] in Body fluid

232

1.25

0.52

2.3

2.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.50

0.51

2.8

5.0

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

315

1.21

0.50

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.46

0.50

1.2

—

(3017569) Oxygen content in Arterial blood

189

1.27

0.49

1.8

2.3

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.56

0.49

1.0

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

521

1.15

0.48

1.9

1.7

mu/l

298.9

289.4

0.13

478

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.40

0.48

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.45

0.48

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

235

1.24

0.48

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

390

3710

1.06

0.47

4.2

3.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

102

1.37

0.47

1.8

1.7

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.47

0.47

1.7

3.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

664

1.13

0.46

1.4

e6/l

738.8

1042.7

0.20

535

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

664

1.13

0.46

1.4

e6/l

6.4

26.0

1.33

504

(3003740) Influenza virus B Ag [Presence] in Specimen

273

1.21

0.46

1.4

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

129

1.32

0.45

1.4

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

274

1.21

0.44

1.4

1.1

—

(3014051) Protein [Presence] in Urine by Test strip

791

1.12

0.43

2.3

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.61

0.43

1.2

u/l

18.4

11.2

—

(3008295) Osmolality of Serum or Plasma

360

0.83

0.42

1.2

1.3

mosm/kgh2o

278.3

275.7

0.21

267

(3035933) Granulocytes/100 leukocytes in Blood

1.40

0.42

1.1

1.8

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.43

0.41

1.2

1.1

83.6

83.0

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

158

1.27

0.41

1.0

u/ml

0.6

0.4

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

7.3

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.00

0.41

0.0

2.2

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

296

1.18

0.40

1.5

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

168

1.25

0.40

1.4

1.3

nmol/l

0.9

1.1

0.51

129

(3039000) Anion gap in Blood

844

1.10

0.40

7.1

7.3

mmol/l

11.0

11.2

0.18

751

(3018572) Chloride [Moles/volume] in Blood

844

1.10

0.40

7.1

7.3

mmol/l

106.7

105.2

2.15

751

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

150

1.27

0.40

1.8

1.5

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.40

0.0

1.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.31

0.39

1.0

—

(3016330) Potassium [Moles/time] in 24 hour Urine

1.43

0.39

1.0

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

106

0.66

0.39

1.1

1.5

—

(3013727) Leukocytes other/100 leukocytes in Blood

133

1.28

0.38

2.5

3.8

52.0

54.1

0.16

128

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

1.39

0.38

1.0

1.1

—

(40767503) Oxygen content in Capillary blood by calculation

800

1.10

0.37

2.4

2.5

15.8

16.0

0.21

409

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.35

0.37

1.8

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.39

0.36

1.2

1.3

93.2

81.4

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

157

0.76

0.35

1.1

1.3

mmol/l

5.9

6.1

0.65

149

(3006653) Thiamine [Moles/volume] in Blood

162

1.24

0.35

1.1

1.2

nmol/l

154.4

139.1

0.55

162

(3052592) Norovirus Ag [Presence] in Stool

1.37

0.34

1.4

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.36

0.34

1.2

1.1

—

(40758292) HTLV I+II Ab panel - Serum

1.36

0.34

1.2

1.4

—

(3047181) Lactate [Moles/volume] in Blood

124

1152

1.08

0.34

6.4

6.5

mmol/l

1.2

1.3

0.66

115

1020

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.34

0.34

1.1

—

(3034426) Prothrombin time (PT)

1.32

0.33

1.1

1.3

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.32

0.33

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.70

0.33

1.2

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.69

0.33

1.2

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

202

1.19

0.31

1.9

2.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

160

1696

0.94

0.30

1.8

—

(21491868) Cryoglobulin [Mass/volume] in Serum

120

1.25

0.30

1.1

1.3

g/l

—

0.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

185

0.81

0.29

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

711

1.08

0.27

1.6

—

(3035880) pH of Pleural fluid

234

1.15

0.26

1.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

234

1.15

0.26

1.5

1.1

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

178

1.18

0.26

1.1

u/ml

2.8

—

(3025130) Human papilloma virus identified in Specimen

225

1.16

0.26

1.7

—

(3005033) Fetal Nuchal fold Thickness US

0.71

0.24

1.2

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

180

1.17

0.23

1.5

1.8

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

143

1.19

0.23

1.1

1.2

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.22

0.22

1.0

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

0.00

0.21

0.0

1.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

0.21

0.0

3.0

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

0.00

0.21

0.0

6.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

1.23

0.21

1.3

52.6

30.9

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

104

0.77

0.21

1.1

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

104

0.77

0.21

1.1

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

105

0.76

0.21

1.1

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

105

0.76

0.21

1.1

1.4

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.22

0.20

1.0

1.3

nmol/l

6.2

197506.2

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

155

1.16

0.19

1.1

u/l

0.9

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

193

1.14

0.19

1.0

u/ml

6.5

2.0

—

(3021901) Oxygen saturation in Capillary blood

704

1.07

0.19

2.7

2.8

—

(3000012) Reticulocyte production index

203

1.13

0.19

1.1

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

121

0.83

0.18

1.0

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

252

1.11

0.17

1.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

119

1.18

0.17

1.6

1.8

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

589

0.93

0.17

1.5

1.3

iu/l

33.5

34.6

0.09

499

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.13

0.17

7.6

7.8

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

205

0.88

0.17

1.1

1.2

mmol/l

12.8

12.0

0.18

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.11

0.17

1.1

1.3

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

0.72

0.17

1.0

1.3

mmol/l

0.4

2.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

1.18

0.16

1.4

1.3

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.18

0.16

1.3

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

244

1.11

0.16

1.1

1.2

—

(3028271) Lactate [Moles/volume] in Capillary blood

593

1.06

0.16

2.0

1.9

mmol/l

1.7

0.10

576

(4027681)

140

1.14

0.15

1.1

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

112

1.16

0.14

1.2

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

862

1.05

0.13

1.6

1.8

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.17

0.13

1.1

2.0

—

(1617658) Protocol used for examination of sentinel lymph nodes

248

1.09

0.12

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1.18

0.12

1.2

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

299

1.07

0.10

1.4

1.6

—

(44806420)

125

1.12

0.10

2.7

2.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

310

1.07

0.09

1.2

1.4

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

196

0.92

0.09

3.6

4.1

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.79

0.08

1.6

ng/l

88.6

143.3

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

156

1.09

0.08

1.0

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

0.80

0.07

1.5

1.4

—

(3020650) Glucose [Presence] in Urine

1.04

0.07

1.6

—

(3029075) Extractable nuclear Ab panel - Serum

1.03

0.07

1.0

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.03

0.07

1.1

1.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.03

0.07

8.4

8.2

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

0.86

0.07

2.4

2.2

nmol/l

115.3

145.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.82

0.07

1.4

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

1.03

0.07

1.7

1.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.87

0.06

8.5

7.8

—

(3045716) Anion gap in Serum or Plasma

173

0.92

0.06

1.8

2.2

mmol/l

9.0

9.2

0.09

141

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

197

1.07

0.06

1.2

1.1

nmol/l

0.3

14.8

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

345

0.96

0.06

1.1

1.3

mmol/l

7.4

7.5

0.06

246

(3040151) Glucose [Moles/volume] in Capillary blood

405

1.04

0.05

15.8

6.8

mmol/l

7.6

7.5

0.01

336

(3006576) Bicarbonate [Moles/volume] in Blood

120

0.92

0.05

8.4

6.8

mmol/l

24.9

24.6

0.15

106

(3039443) Prostate specific Ag panel - Serum or Plasma

512

0.98

0.03

1.4

1.7

—

(3045788) Cell count panel - Pleural fluid

399

1.03

0.03

1.5

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

270

1.04

0.03

1.1

1.0

ng/l

269.6

323.3

0.84

175

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

271

1.03

0.02

1.1

1.0

ng/l

64.0

46.0

0.32

173

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

272

1.03

0.02

1.1

1.0

ng/l

709.7

681.4

0.10

171

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

323

1.02

0.01

1.6

1.4

26.3

29.2

0.22

196

(3024263) Appearance of Synovial fluid

204

1.03

0.00

1.2

1.6

—

(40768795) Lymph node Pathology biopsy report

324

1.02

0.00

1.2

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

1.02

0.00

1.3

nmol/l

139.8

125.9

—

(3015183) Erythrocyte sedimentation rate

102

0.98

0.00

1.4

1.3

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

112

0.98

0.00

1.3

1.8

ug/l

1925.2

89.2

0.45

102

(3037556) Urate [Mass/volume] in Serum or Plasma

115

1.04

0.00

1.5

1.4

—

(40768793) Breast Pathology biopsy report

738

1.00

0.00

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

825

0.99

0.00

1.7

1.6

mg/l

3.5

3.8

0.06

604

(3022806) Fractional oxyhemoglobin in Capillary blood

494

0.99

0.00

2.0

1.9

88.3

89.2

0.48

486

(3010726) Horse dander IgE Ab [Units/volume] in Serum

227

1.01

0.00

1.0

u/ml

1.0

2.1

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.0

1.0

—

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.90

0.00

1.3

1.2

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

0.97

0.00

1.3

u/l

42.0

582.2

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.98

0.00

1.0

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

0.00

0.0

1.1

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

25.8

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.98

0.00

1.0

1.1

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.4

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.01

0.00

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.98

0.00

1.0

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

0.98

0.00

1.0

1.1

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.98

0.00

1.0

1.5

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

1.9

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

100

1.00

0.00

1.1

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

0.0

1.6

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

0.93

0.00

1.2

1.4

75.7

76.2

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(4133840)

0.85

0.00

1.0

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(40757373) Influenza virus identified in Isolate

0.96

0.00

1.9

1.4

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

2.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.96

0.00

2.4

2.2

—

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.90

0.00

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

1.9

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.00

0.0

2.4

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.0

9.6

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_BENIGN_CAECUM and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_BENIGN_CAECUM	1.248 [1.11, 1.4]	< 0.001
Birth year	0.991 [0.98, 1.0]	0.036

During the follow-up period (1.1.1998 — 31.12.2019), 1399 out of 7195 females with CD2_BENIGN_CAECUM died.

Males

Parameter	HR [95% CI]	p-value
CD2_BENIGN_CAECUM	1.395 [1.23, 1.58]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.006

During the follow-up period (1.1.1998 — 31.12.2019), 1984 out of 6799 males with CD2_BENIGN_CAECUM died.

Mortality risk

Mortality risk for people of age

years, who have CD2_BENIGN_CAECUM.

N-year risk	Females	Males
1	0.101%	0.269%
5	0.735%	1.517%
10	1.712%	3.638%
15	3.252%	7.042%
20	5.608%	11.836%

Relationships between endpoints

↥

Index endpoint: CD2_BENIGN_CAECUM – Benign neoplasm: Caecum

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Benign neoplasm: Caecum

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints